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Abstract
EVOLUTION AND DIVERGENCE OF THE STRUCTURAL AND PHYSICAL
PROPERTIES OF DNA BINDING BY METHYL-CYTOSINE BINDING
DOMAIN FAMILY MEMBERS 2 AND 3
By Jason Matthew Cramer
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2014
Major Director: David C. Williams, Jr., M.D., Ph.D., Associate Professor,
Department of Pathology and Laboratory Medicine, University of North CarolinaChapel Hill, Chapel Hill, North Carolina
The studies presented in this dissertation, Evolution And Divergence Of The Structural
And Physical Properties Of DNA Binding By Methyl-Cytosine Binding Domain Family
Members 2 And 3, pertain primarily to two key epigenetic regulators involved with the
biological interpretation of methylated DNA marks. We provide insights into the
emergence and evolution of the MBD2 and MBD3 and how those molecular entities
influence heritable changes in gene activity. We further provide details regarding the
mystery surrounding MBD3 function and the MBD2-mediated capacity of primitive
animals to carry out methylation-specific epigenetic mechanisms. In chapter two, we
describe the DNA binding properties of MBD2 and MBD3. This study provides
information regarding previously unidentified MBD3 binding properties and potential
biological function. In chapter three, we show that sponges demonstrate a MBD2mediated capacity for binding methylated DNA sites, recruit NuRD components in vitro,
and knockdown of MBD2 in the freshwater desmosponge, Ephydatia muelleri, promotes
an abnormal growth phenotype.
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Chapter 1- Introduction

When we refer to DNA, we often speak of the molecule as a “template” used in the
production of proteins. While one may picture a machine assembly line wherein pieces
are assembled to construct a whole, operational structure, DNA functionality often does
not result in the production of identical parts. DNA serves as a manuscript that may be
interpreted in a number of different ways with many different outcomes. This script may
be altered, thereby changing meaning, and thus interpretation. Alteration may occur in
the form of changes to letters and words or even sentence structure. But, modification
may also involve no apparent change to the words, or their meaning. Subtle emphasis or
de-emphasis of words, sentences, or whole sections of the script may occur leading to the
disuse of those portions of script. When speaking of DNA, these subtle changes in
emphasis often result in alteration of gene function.
Epigenetic phenomena are processes that cause heritable changes to gene
expression without altering genetic sequences. The coding of these occurrences can
reside in modifications to histones and DNA. Scientists study these events through a
variety of biochemical, bioinformatics, and molecular biology approaches. Study of
epigenetic phenomena along with the functional and mechanistic changes they cause has
expanded not only our understanding of human health and disease, but also of the
evolutionary processes driving vertebrate evolution.
Collected epigenetic information is translated into an understanding of the
“epigenome”. To better understand the biological significance of these phenomena, the
epigenome must be mapped. Unfortunately, epigenetic programming is highly variable
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and tends to be subject to the internal conditions of individual cells. Nevertheless,
numerous research projects are underway with the aim of elucidating epigenetic signaling
events on several levels.
This thesis represents one of those projects. Specifically, the information presented
herein sheds further light on the physical mechanisms and dynamics of epigenetic
machinery at both ends of the metazoan spectrum. By describing current protein-protein
and protein DNA interactions in their evolutionary context we can better elucidate the
processes by which new protein properties emerge, the underlying mechanisms by which
biological systems function, and how the diversity of living forms in nature came to be.

1.1 DNA Methylation
DNA methylation is the most abundant and extensively characterized of the
identified eukaryotic epigenetic modifications (1). From plants to mammals, DNA
methyltransferases (DNMTs) carry out DNA methylation through the transfer of a methyl
group from the methyl donor S-adenosyl methionine (SAM) to a cytosine (figure 1.1); the
addition of a methyl group to the 5-position of the cytosine ring in a cytosine-guanine
dinucleotide (CpG) forms 5-methylcytosine (5mC). In humans, this phenomenon is
important for numerous processes including embryogenesis, stem cell differentiation,
genomic imprinting, X chromosome inactivation, and has been associated with
transcriptional silencing and tumorigenesis (1-4).
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!
DNMT

SAMCH3

CH3

SAH

Cytosine

5’ Methyl-cytosine

Figure 1.1: Image showing the process of DNA methylation.

1.1.1 DNA methylation is evolutionarily ancient
DNA methylation represents an important epigenetic signal found throughout the
three domains of life, though the roles and targets of DNA methylation vary among the
kingdoms of organisms. The process may have evolved in bacteria as a barrier against
genome invasion by viral or other foreign DNA (3). The high degree of conservation in
the catalytic motifs of DNMTs across prokaryotic and eukaryotic species also suggests
that cytosine methylation is an ancestral mechanism.
In kingdom Eukaryota, 5mC and DNMTs are found in animal, plant, fungal, and
protozoan lineages (5-7). Methylation patterns are also observed at the very base of the
animal kingdom in sponges (8) presupposing the omnipresence of methylation and
methylation machinery throughout higher levels of Eukaryota. Interestingly, this is not
the case.
Patterns of DNA methylation changed during the transition from invertebrate to
vertebrate life. Vertebrates tend to show global methylation often in promoter regions
while invertebrates harbor “mosaic” methylation patterns in gene bodies (9). The global
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methylation observed in vertebrates appears to correlate with an expansion of the DNMT
and MBD families (10).
While 5mC and DNA methylation are abundant in vertebrates, these marks are not
ubiquitous, and further, many invertebrates lack methylation altogether (9). Though
several invertebrate organisms do not experience detectable methylation, including
several commonly used invertebrate model organisms (e.g., yeast, fruit fly, and worm)
(11), research continues to demonstrate the pervasiveness of cytosine methylation as an
evolutionarily ancient genomic regulatory mechanism. Given that DNA methylation is a
mechanism for regulating endogenous gene expression and reducing transcriptional
noise, a reduction in unnecessary gene expression may have permitted the increase in
gene number and in complexity that characterizes metazoans, i.e., animals (12).

1.1.2 DNA methylation in sponges
Sponges represent the most ancient and primitive metazoan lineage (13) and,
despite their distinct morphological separation from other animals, studies of sponges
have shed light on the molecular evolution of animals. Like higher animals, the sponge
genome harbors genes crucial for growth, differentiation, cell-cycle control, cell
adhesion, innate immunity, and allorecognition (14). Sponges also share in common with
animals numerous transcription factor, sensory transduction, and cell adhesion genes
(15). Sponges, however, have nearly two times more genes than eumetazoans (i.e., “true”
animals) (16), discrediting the idea that animal evolution resulted from an increase in the
number of genes.
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Though the recently sequenced Amphimedon queenslandica genome indicates the
numerous similarities in the molecular framework between sponges and other animals,
much is still unknown regarding the epigenetic machinery in place at the dawn of
metazoans. Thus, analysis of sponge epigenetic mechanisms and structures can
potentially uncover the genomic innovations allowing for the multicellular life and shed
light on the evolutionary underpinnings of cancer. Indeed, numerous “founder” genes
associated with the appearance of metazoan multicellularity connect with cancer onset
and progression (15).
Earlier analysis of sponge methylation levels detected up to 9.4% 5mC in a sample
of 15 sponge species (8). The A. queenslandica genome exhibits germline cytosine
methylation indicated by a depletion of CpGs with corresponding TpG and CpA
dinucleotide excess relative to overall GC content. Four putative orthologs of DNMT1
were identified in A. queenslandica along with one copy of a DNMT-like gene (Pohlman
D, unpublished data). Swiss-Prot analysis of A.q. revealed presence of partial sequences
similar to the glycosylase domain of MBD4 along with other predicted MBD proteins,
including a MBD2-like protein (8, 17).
Another sponge, Ephydatia muelleri, is an emerging model system to study aspects
of animal development (14). E. muelleri harbors epigenetic machinery, discussed in detail
later, that presumptively allows for the same epigenetic signaling as observed in higher
animals. Two supposed orthologs of DNMT1 were discovered in the E. muelleri genome
along with one copy of a DNMT3-like gene. An ortholog of MBD2 (i.e., Mbd2/3) was
also detected (Pohlman D, unpublished data). Despite the presence of DNMTs and MBDs
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in these two sponges, the methylation pattern (i.e., global or mosaic) has not yet been
determined.

1.1.3 DNA methylation in mammals
DNA methylation occurs at 70-80% of CpGs in vertebrates although this
dinucleotide represents a very small percentage of the base composition of DNA (18).
The CpGs comprising the genome are primarily found concentrated into regions known
as “CpG-islands” (CGIs) and represent a very small percentage (1-2%) of the genome in
its entirety (19, 20). Approximately 60% of active genes contain CGIs in their promoter
regions. These regions are largely unmethylated and less subject to CpG loss experienced
by the rest of the genome whereas CpGs outside of CGIs tend to be very highly subject to
methylation (19). Different cell types show different gene expression patterns, an
observation that suggests that CpG methylation differs across different cell types.
DNA methylation patterns become distinctly altered early in mammalian embryonic
development (21, 22). Fertilization initiates a period of genome-wide DNA
demethylation and subsequent de novo methylation necessary for methylation
reprogramming in somatic cells after implantation and resetting gamete-specific patterns
in germ cells. Beyond these genome-wide changes, de novo methylation and
demethylation occur during tissue-specific differentiation (23-25).
DNMT family members DNMT1, DNMT3A, and DNMT3B maintain mammalian
DNA methylation patterns through the activity of a conserved C-terminal
methyltransferase domain (5). DNMT1 preserves DNA methylation patterns during
replication by adding methyl groups symmetrically opposed to methyl groups of hemi-
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methylated CpG sites found on newly replicated DNA. DNMT1 localizes to these sites
likely assisted by two proteins that bind hemi-methylated DNA: the cofactor ubiquitinlike, containing PHD and RING finger domains 1 (UHRF1) and proliferating cell nuclear
antigen (PCNA) (21, 26). DNMT3A and DNMT3B have no preference for
hemimethylated CpGs. Both establish methylation patterns during early stages of
embryonic mammalian development through de novo DNA methylation activity (27).
Though cytosine methylation is considered to be a stable modification, a variety of
mechanisms have been proposed for demethylation. During one such mechanism, 5mC is
oxidized to form 5-hydroxymethylcytosine (5hmC) in mammals by the ten eleven
translocation (TET) family of enzymes. Several mechanisms (e.g., the DNA base
excision repair, BER, pathway) are proposed to occur subsequent to the conversion of
5mc to 5hmC and ultimately lead to a decrease of the methylation mark (28, 28, 29).
These demethylation pathways may be important for normal developmental processes, as
well as the global hypomethylation observed during cancer progression; downstream
removal of 5hmC may be a critical event epigenetic gene regulation (28, 30, 31).

1.1.4 Aberrant DNA methylation and cancer
In normal cells, DNA methylation occurs primarily in repetitive genomic regions,
including satellite DNA and parasitic elements (e.g., long and short interspersed
transposable elements) (32). DNA methylation has been linked to regulation of gene
expression and genome stability. CGIs around promoters are commonly unmethylated
(33) with few exceptions (e.g., differentially methylated regions associated with gene
imprinting). Despite early predictions gene body methylation has been associated with
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transcription (34, 35). Methylation of gene promoter and enhancer regions, however,
correlates with transcriptional silencing through interference of transcription factor
binding and formation of heterochromatin by methyl DNA-binding proteins (MBDs)
(36).
The relationship between disrupted DNA methylation patterns and cancer was first
observed when hypomethylated cancer cells were identified and has since been
extensively studied and argued (37, 37-39). Recent advances in our understanding of
epigenetic modification has shown that human cancer cells undergo global changes in the
epigenetic landscape including genome-wide hypomethylation concurrent with promoter
CGI hypermethylation of tumor suppressor genes including BRCA1, VHL, and
p16/INK4a (40); these alterations are now considered hallmarks of cancer. Further, these
cells harbor numerous genetic alterations that, along with aberrant changes to the
methylome, promote cancer progression.
The mechanism of gene silencing by promoter hypermethylation can occur by
several modes including direct obstruction of transcriptional machinery and nucleosome
remodeling activities that make transcriptional start sites inaccessible. DNA
hypomethylation is often an early tumorigenic event that occurs in cancer cells primarily
through demethylation in genomic repetitive regions (32, 40, 41). DNA demethylation
can have mechanistic implications: removing methyl groups relaxes chromatin structure
allowing histone acetylation and the binding of transcriptional complexes. Thus, loss of
methylation can lead to activation of normally silent genes, including oncogenes such as
those in the ras family (42). Relaxed chromatin also may be more prone to genetic
mutation and chromosomal rearrangements (43).
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1.2 Methyl-cytosine binding proteins 2 and 3, NuRD, and vertebrate evolution
The canonical MBD binds symmetrically related methyl-CpG dinucleotides.
Though several MBD proteins have been identified, only MBD2 and MBD3 homologs
have been identified in invertebrate genomes. MBD2/3 is the presumed invertebrate
ancestor to the vertebrate MBD2 and MBD3 proteins; a single gene encodes MBD2/3,
whereas two separate genes produce MBD2 and MBD3 (44). Vertebrate Mbd2 and Mbd3
possess nearly identical intron-exon structure and MBD2 and MBD3 exhibit 71%
sequence homology. These and other observations have led to the supposition that a gene
duplication event resulted in two genes distinct from Mbd2/3 at a time concurrent with
the emergence of vertebrates (3).
Mammalian MBD2 selectively binds methylated DNA whereas MBD3 does not,
although it does preferentially localize to methylated CpG dinucleotides (45). MBD3
differs from MBD2 at two amino acid residues critical for mCpG binding. In mammalian
MBD3, a histidine residue (amino acid position 30) and a phenylalanine (position 34)
replace lysine and tyrosine residues in MBD2, respectively. The latter substitution
disrupts the interaction between the methyl group of methylcytosine and the MBD3
MBD; selectivity for methylated DNA is greatly reduced. Although these substitutions
clearly abolish methyl-CpG selectivity, the biological purpose of MBD3 and much of its
structure remain unclear.
MBD2 and MBD3 structural components primarily consist of a methyl-cytosine
binding domain followed by a region implicated in binding the RbAp46/48 homolog p55
(46) and a C-terminal coiled-coil region. Human MBD2b shares 70% sequence homology
with human MBD3 prompting in vitro comparisons between the two proteins. The human
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!
MBD2a
isoform possesses an N-terminal GR-rich region that likely serves as a DNA
!
!
tether
yet operates with lower affinity for methylated DNA in vitro than MBD2b (47).
!
!
!
!
!
GR-rich
MBD
p55 binding region
Coiled-coil !
!
region
(p55BR)
region
!
MBD2a
!
!
!
!
!
!
!
!
MBD
p55 binding region
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Figure 1.2: MBD2 and MBD3 domain organization. GR, glycine-arginine repeat region;
MBD, methyl-binding domain.

Structural analysis of other MBD family members (i.e., MeCP2 and MBD1)
elucidated the methyl-cytosine binding domain selectivity for mCpG dinucleotides: basespecific interactions between conserved arginine and tyrosine residues and the mCpG
dinucleotide. A hydrogen bond network forms between arginine residues 22 and 44 and
the symmetrically related guanine bases of the mCpG dinucleotide. The aliphatic portions
of the arginine residues further pack against the methyl groups of the symmetric methyl	
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cytosine bases. The critical tyrosine residue forms a hydrogen bond with the methyl
group of a methyl-cytosine through water-mediated interaction (48, 49). Analysis of the
MBD2 MBD solution structure elucidated a similar binding event, but further revealed a
specificity for CGG sequences that enhances the selectivity of chicken MBD2 (cMBD2)
for mCpGs driven in part by additional hydrogen bonding formed between lysine 30 and
the second guanine of the mCGG sequence (50).
Comparison of cMBD2 and MBD3 MBD solution structures reveals high similarity
between the two proteins and both complement the global fold of other methyl-cytosine
binding domain proteins: the topology consists of a four-stranded β-sheet, a flanking αhelix, and a C-terminal loop (45, 50). The second and third beta sheets form a long,
finger-like projection that extends into the major groove to form critical DNA-specific
contacts. A long loop connects the strands forming this projection, and for cMBD2,
residues found in this loop form contacts with DNA that further stabilize the interaction
with methylated DNA (50). Notably, this loop is less well ordered for MBD3 (45); the
absence of the amino acids crucial for methylation selectivity at the base of the projection
destabilizes its overall structure, thereby disrupting the hydrogen bond network necessary
for methylation-specific binding. Again, such information brings into question the
functional role of MBD3.
Other observations further highlight the mystery surrounding mammalian MBD3
function: (1) Non-mammalian vertebrates have been identified that share high amino acid
sequence identity with mammalian MBD3 yet preferentially bind methylated DNA, e.g.,
amphibian MBD3 (3, 47); (2) while MBD2-null mice experience only subtle defects
MBD3-null mice die early in embryonic development (51); (3) both proteins associate
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with the Mi-2/nucleosome remodeling and deacetylation complex (i.e., NuRD complex)
in a mutually exclusive manner (52); (4) MBD3/NuRD bars reversion of murine stem
cells to ground-state pluripotency (66); (5) MBD3/NuRD localizes to promoters (53, 54),
gene bodies, and enhancers of active genes (54).
The NuRD complex is an ATP-dependent chromatin remodeling complex that
facilitates multifaceted chromatin remodeling activities and is implicated in
transcriptional silencing. The complex tethers to DNA through its associated MBD
protein, thus coupling reading methylation marks with histone modification. As seen in
figure 1.3, six core proteins comprise the complex and constitute its ability regulate gene
expression at the chromatin level: MBD2 or MBD3; histone deactylase (HDAC) 1 or
HDAC2; chromatin remodeling enzyme Mi-2α (CHD3) or Mi-2β (CHD4); p66α
(GATA2A) or p66β (GATA2B); metastasis-associated (MTA) protein (i.e., MTA1,
MTA2, or MTA3); retinoblastoma-binding protein (RBBP; also known as RbAp48) 4 or
RBBP7 (RbAp46). The MBD protein targets the complex to DNA while HDAC1 or
HDAC2 enzymatically removes acetyl groups from histone tails. The Mi-2 subunit
carries out chromatin remodeling in part by repositioning nucleosomes. The p66α, p66β,
RBBP4, and RBBP7 subunits are likely structural subunits of the complex that interact
with histone tails. The p66α/β proteins contain two highly conserved regions: an Nterminal coiled-coil domain (CR1) and a C-terminal GATA-like zinc finger domain
(CR2) (55, 56). The MTA protein is thought to localize the complex to different cellspecific targets by associating with transcription factors (57).
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Figure 1.3: NuRD complex architecture. The human NuRD complex contains one homolog of six
different core proteins: MBD2 or 3; HDAC 1 or 2; RbAp 46 or 48; p66α or β; Mi-2α or β.

The coiled-coil regions of MBD2 and MBD3 bind the p66α coiled coil domain
(CR1) forming a high affinity heterodimeric complex that recruits Mi-2 and correlates
with in vivo
dependent
transcriptional
(58).
interaction is
Figuremethylation
1.1: Components
of MBD2-NuRD.
A) Schematicrepression
representation
of theThis
MBD2NuRD complex.
Domain
of MBD2b: MBDcomplex
is methyl forms
binding domain;
unique amongst
coiledB)coils
in organization
that the heterodimeric
from anti-parallel
CC is coiled-coil domain C) Domain organization   of   p66α:   two   conserved   regions   are  

association between two peptides that are largely monomeric in isolation. Helical content
seen. CR1 is a coiled coil domain; CR2 includes a GATA zinc finger domain.

and specific electrostatic interactions between charged residues on the individual coiled
coil domains drive the high affinity binding observed (59). This suggests that isoforms of
MBD2, MBD3, and p66 exhibiting a reduction in helical content will bind with reduced
affinity for p66. Indeed, this is the case for MBD3L1 and MBD3L2, homologues of
5
MBD3 lacking a methyl-cytosine binding domain
but containing a C-terminal coiled coil

(59).
MBD2 and MBD3 contain a region implicated in binding the RbAp46/48 homolog
p55 in Drosophila (46). The p55-binding region (p55BR) is found between the methylcytosine binding domain (MBD) and the coiled-coil domains of MBD2 and MBD3 and
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recruit the NuRD core components RbAp48, HDAC2 and MTA2 (Desai, MA,
unpublished data). This region has been determined to display a largely unstructured
architecture in isolation and yet enhances the affinity of MBD2 to methylated DNA
(Desai, MA, unpublished data).
Genes for NuRD complex components have been identified in the earliest
metazoans including Amphimedon queenslandica and Ephydatia muelleri (unpublished
data, Pohlman D.) but it is unclear if their products form a functional complex. We
recently found, discussed in detail later, the E. muelleri MBD2 coiled-coil region binds
the E.m. p66α coiled-coiled domain with low affinity. Further, the human MBD2 coiled
coil domain binds E.m. p66aCR1 and vice versa with higher affinity than the two E.m.
components in complex together (unpublished data). Surface plasmon resonance shows
that the Ephydatia MBD2/3 methyl-cytosine binding domain binds methylated DNA with
approximately 200-fold higher affinity than unmethylated DNA, similar to that of the
human MBD2 (unpublished data). Isothermal titration calorimetry indicates that the
coiled-coil region from the E.m. MBD2/3 binds to the human p66αCR1 with higher
affinity than the weakly binding Ephydatia p66αCR1 isoform; the human isoforms bind
each other with an affinity approximately 1,000-fold higher. These findings suggest that
as coiled coil domains evolved in vertebrates, high affinity binding between these NuRD
components developed so as to decrease competition with other coiled-coil proteins.
1.3 The coiled coil motif in evolution
Coiled-coils are an important structural motif involved in a diverse array of
important protein interactions. They are a highly adaptable class of proteins both in terms
of structure and function, and they are prevalent in all domains of life indicating the
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evolutionary success of the motif. Coiled-coil domains are predicted in approximately
10% of eukaryotic proteins, and less than 5% in prokaryotes (60, 61). It has been
suggested that the expansion of coiled coils and their interactions underlies metazoan cell
and tissue structure variation (62).
The coiled-coil typically consists of two or more α-helices wrapped around one
another. Coiled-coils are characterized by amino acid sequences forming a heptad repeat
pattern. In this sequence, the first and fourth residues are hydrophobic, and residues in the
fifth and seventh position are primarily charged or polar (63). Coiled-coil segments may
be unfolded in monomeric form and then fold during interaction with a binding partner
(64). A two-state transition often describes the folding and unfolding of coiled coils, i.e.,
unfolded peptide monomers cooperatively fold to form coiled-coil dimers or oligomers
(63).
Despite the simplicity of the architecture, the coiled-coil motif exhibits considerable
variation in terms of stability and dynamics. These characteristics may in turn determine
the ability of coiled-coil domains to evolve; poorly packed and disordered proteins may
show a high ability to evolve. Protein stability may then be tailored to the biological
function. Coiled coils participate in numerous cellular functions and the simple yet
dynamic nature of their structure may prompt binding with various partners and the
formation of multiple complexes. However, binding partner selection appears to be an
intricate process during which evolution may fine-tune each protein so as to enhance
binding and allow for new biological functions, or the emergence of novel proteins (65).
Comparisons of sequence and structure provide insight regarding evolutionary
relationships between proteins. The relatively simple repeating sequence of the coiled
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coil motif suggests that it likely emerged multiple times during protein evolution. Small
evolutionary changes in sequence and structure may result in large changes in binding
dynamics, and thus biological function. The paths leading to novel functions likely
proceed through states in which isoforms and relatively unstable structures emerge and
coexist (65); one or more of these forms may perform new tasks beneficial for the
organism resulting in the evolution of a new biological function. This scenario might very
well be represented by the subtle changes over time in the coiled coil regions of p66α and
MBD2 and MBD3.
The role of DNA methylation and methyl-cytosine binding domains has clearly
changed during the course of metazoan evolution. The ancestral MBD may have played a
role in gene regulation or modifying chromatin structure, but the expansion of the
methylation landscape in vertebrate genomes created an environment in which new
dynamic properties of regulatory proteins were required; expansion of the first MBD’s
functional role may have occurred concomitant to changes in the DNA methylome. Of
course, it has been argued also that the methyl-CpG binding proteins provided both
greater transcriptional control and protection against mutation, and thereby contributed to
the global expansion of methylated DNA within the evolving vertebrate genome (3).
Such contrasting arguments remain to be resolved. Thus, continued study of MBDs
across the animal kingdom will provide further detail of the changing role of DNA
methylation and gene regulation in animal evolution.
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Chapter 2- Probing the Dynamic Distribution of Bound States
for Methyl-cytosine Binding Domains on DNA

2.1 ABSTRACT
Although highly homologous to other methylcytosine binding domain (MBD)
proteins, MBD3 does not selectively bind methylated DNA and thus, the functional role
of MBD3 remains in question. To explore the structural basis of its binding properties
and potential function, we characterized the solution structure and binding distribution of
the MBD3 MBD on hydroxymethylated, methylated and unmethylated DNA. The overall
fold of this domain is very similar to other MBDs, yet a key loop involved in DNA
binding is more disordered than previously observed. Specific recognition of methylated
DNA constrains the structure of this loop and results in large chemical shift changes in
NMR spectra. Based on these spectral changes, we show that MBD3 preferentially
localizes to methylated and, to a lesser degree, unmethylated cytosine-guanosine
dinucleotides (CpGs), yet does not distinguish between hydroxymethylated and
unmethylated sites. Measuring residual dipolar couplings (RDCs) for the different bound
states clearly shows that the MBD3 structure does not change between methylation
specific and non-specific binding modes. Furthermore, RDCs measured for MBD3 bound
to methylated DNA can be described by a linear combination of those for the methylation
and non-specific binding modes, confirming the preferential localization to methylated
sites. The highly homologous MBD2 protein shows similar but much stronger
localization to methylated as well as unmethylated CpGs. Together, these data establish
the structural basis for the relative distribution of MBD2 and MBD3 on genomic DNA
and their observed occupancy at active and inactive CpG-rich promoters.
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2.2 INTRODUCTION

The mammalian methylcytosine binding domain proteins (MeCP2 and MBD1-4)
selectively bind symmetrically methylated CpGs through a common methylcytosine
binding domain (MBD)(1) and likely arose from a gene duplication event of a single
common ancestral protein (MBD2/3)(2). The preference of MBD2 for methylated DNA
has been retained in both invertebrates and vertebrates; (3) however, the highly
homologous MBD3 shows little to no preference for methylated DNA as a result of key
differences in amino acids critical for DNA contact within the MBD (4, 5). Both proteins
recruit a nucleosome remodeling and deacetylase (NuRD) complex (6) but in a mutually
exclusive manner (7). The MBD2-NuRD complex has been specifically shown to
promote methylation-dependent gene silencing and represents a potential therapeutic
target for gene reactivation, (6, 8-13) while the function of the MBD3-NuRD complex
has not been clearly delineated.
A recent study showed that MBD3 co-localizes with Tet1 and suggested
preferential binding to hydroxymethylated CpGs (hmCpG) (14). Subsequent experiments,
however, failed to show a binding affinity preference for hmCpG (15), but instead found
that both MBD2 and MBD3 preferentially localize to transcriptional start sites with CGIs
(16, 17). MBD2 predominates at methylated CGIs and the associated genes show reduced
expression, while MBD3 appears to favor transcriptional start sites with unmethylated
CGIs and is enriched at active promoters (16).
To help elucidate the structural differences between MBD2 and MBD3 and evaluate
the recently proposed hydroxymethylation selectivity, (14) we determined the structure of
MBD3 bound to DNA containing a single hmCpG dinucleotide. We observed that MBD3
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adopts a very similar structure to that of MBD2. A critical loop connecting two antiparallel β strands is less well defined in MBD3, but otherwise the two structures are
nearly identical. Furthermore, we show that MBD3 does not specifically recognize
hmCpG, but chemical shift analysis indicates that MBD3 binds differently to mCpG and
spends a significant proportion of time on methylated sites. Occupancy depends on the
number of unmethylated sites available and MBD3 demonstrates chemical shift
averaging indicative of fast exchange between the methylated and non- specific binding
modes.
Residual dipolar coupling (RDC) analysis confirms our findings by showing that
MBD3 preferentially localizes to mCpG sites and that MBD3 adopts a very similar
structure on mCpG, CpG, and hmCpG DNA. As expected MBD2 shows a strong
preference for mCpG sites, exclusively localizing to the mCpG dinucleotide. We also
find that MBD2 localization is influenced by unmethylated CpG density, and that MBD2
shows an unanticipated additional weak localization to hmCpG.
Taken together this information leads to a model in which the methylation
specificity and occupancy of an MBD can be titrated by single amino acid substitutions.
Importantly, the tendency to localize on a specific site does not necessarily translate into
a global binding affinity preference. These data are consistent with recent studies
showing that both MBD2 and MBD3 localize to transcription start sites associated with
CGIs (16, 17, 31). The ability to condense chromatin and silence transcription at or near
methylated CGIs reflects MBD2 high affinity and stable occupancy of mCpG sites.
Hence, we propose that MBD3 evolved, at least in part, to counterbalance MBD2 on
unmethylated CGIs. The presence of MBD3 at unmethylated CGIs could modify the
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distribution of MBD2 and potentially mitigate strong silencing by the high- affinity, more
strongly localizing MBD2 protein, thereby preserving bivalency with respect to
transcription.

2.2.1 Use of NMR spectroscopy
Some of the key ideas of nuclear magnetic resonance (NMR) spectroscopy are
discussed in this section. It should be noted that the description of NMR spectroscopy
presented is not meant to offer a complete depiction of the process and the theory
underlying its performance. The purpose of the material here is to provide some
background that may allow the reader to better understand the NMR-derived data
presented later in this chapter.
NMR spectroscopy represents a powerful tool for studying how biology works at
the molecular level. The process provides access to information useful for studying
several aspects of chemical biology on the atomic level, including: analysis of protein
structure, protein folding dynamics, and protein-protein and protein-DNA interactions.
Thus, NMR spectroscopy enhances our capacity to collect structural data from which
atomic-level functional understanding can be developed.

2.2.1.1 Key principles
In quantum-mechanical theory, each atomic nucleus possesses a property known as
spin. From a classical viewpoint, this attribute allows each nucleus to behave in a manner
similar to a spinning top toy or a gyroscope. On a smooth surface a top spins freely about
its main axis while also moving in a circular motion (i.e., precession) dictated by the
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torque exerted by its weight. Figure 2.1, left image, represents this motion. In the case of
the nucleus, the torque on the nuclear spin results from interaction with the magnetic
field. The spinning top analogy is useful for explaining how the magnetic moments of the
nuclei couple with an applied radiofrequency (rf) pulse and ultimately lead to a
macroscopic oscillating magnetic field detected by a coil within the spectrometer.	
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Figure 2.1: Nuclear spin. Left: a depiction of a spinning top toy. Right: a
depiction of the two different allowed spin states of a 1H nucleus.

In a sample of spin 1/2 nuclei in an external magnetic field, two populations will
emerge, one aligned with the field, and the other against. Nuclei oriented against the
direction of an external magnetic field (designated -1/2) associate with a higher energy
spin state, and those oriented with the direction of the field (+1/2) associate with lower
energy (figure 2.1, right; figure 2.2A). The energy difference between the two spin states
is always very small but nevertheless dependent on the strength of the external magnetic
field. That is, when the external field strength is zero, the two spin states are equally
populated and have the same energy. When the field strength increases, the spin states
diverge creating two distinct energy states. The ability to use strong magnets to
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manipulate these populations of nuclei serves as the basis of NMR spectroscopy.
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Figure 2.2: A) Energy versus magnetic field plot. B) Depiction of the magnetic dipole.

Even in a magnetic field of very high strength, the energy difference between two
spin states is very small and is represented in MHz with the actual energy difference
again depending on the strength of the field and the nucleus involved. For the nuclei used
in this body of work, primarily hydrogen (1H- proton) and nitrogen-15 (15N) nuclei, the
energy difference between their spin states depends upon their respective magnetic
moments. Irradiation of the sample with rf energy that matches the energy difference
between the two spin states may transition some of the nuclei in the lower energy state to
the higher energy state, and vice-versa, at room temperature. Since excitation energy
applied to the sample falls within the radiofrequency range, NMR spectroscopy
represents a very mild manner by which molecular structure may be probed.
Although magnetic fields are uniformly applied to samples, the actual magnetic
field experienced at the level of the nucleus depends upon several environmental factors;
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scanning the energy absorption by nuclei provides highly useful information regarding
the chemical environment in which nuclei exist in a sample. However, the absorption of
radiation is very difficult to detect since the difference between the populations in the two
spin states is very small, as discussed above. To heighten the ability to detect absorption
of radiation, relatively high concentrations of the nuclei observed must be present.
Detection sensitivity depends on the characteristics of the nucleus observed, the
abundance of the nucleus, and the energy difference in the two spin states. Thus, stronger
magnets that produce larger magnetic fields are in continuous development.
Unfortunately, carbon-12, which is highly abundant, produces no signal during NMR
analysis. This is also the case for nitrogen-14. On the other hand, carbon-13 and nitrogen15 isotopes will produce signal, hence their use in NMR studies is highly valuable.
Hydrogen nuclei are the most sensitive to NMR methods and the most extensive
experimentation has been carried out using proton NMR. One might think that since all
protons have the same magnetic moment, then all hydrogen nuclei will behave the same
in a magnetic field. That is, hydrogen atoms might be expected to emit resonance signals
at the same field versus frequency values. Fortunately, this is far from true. Protons in
different compounds respond very differently in NMR experiments. The reason for the
difference in behavior lies outside of the nucleus, in the electron cloud.

2.2.1.2 Shielding and Chemical shifts
As charged particles, electrons will respond to an external field by moving in a
manner that generates a secondary magnetic field opposing the stronger external field. It
has been shown that naked protons resonate at lower field strength than those hydrogen
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nuclei involved in covalent bonds. This behavior results from the secondary field,
generated by the movement of electrons, which shields the proton nucleus from the
applied external field. Thus, the magnetic field strength must increase in order to bring
about resonance (absorption of radiofrequency energy).
The ability to achieve excitement and resonance depends upon the degree of
shielding exerted by surrounding electrons. The degree of shielding experienced by a
proton is determined by the electronegativity of its covalent binding partner and of
surrounding nuclei. For example, a hydrogen atom covalently bound to a bromine atom
will be more de-shielded than one bound to a carbon atom, since the electronegativity
difference between hydrogen and carbon is small. Further, a hydrogen atom in a chemical
environment where it is both covalently bound to an atom with higher electronegativity
and involved in an intermolecular interaction with a different atom of higher
electronegativity (e.g. a hydrogen bond), will be further de-shielded; the proton nucleus
will resonate at a higher frequency than that of a fully shielded nucleus.
The usefulness of NMR results from the interaction of nuclei with surrounding
electrons and other nuclei in the molecule and sample solution. As mentioned earlier,
high electron density around a nucleus produces a field that opposes the external field.
The resonance frequency associated with this phenomenon scales with the magnetic field
strength. Hence if we normalize by field strength, the chemical shift will be the same
across spectrometers. Chemical shifts due to changes in chemical environments are taken
into account by expressing the shift as a relative change in frequency with respect to the
reference compound. To produce an unambiguous signal location, frequency differences
(in Hz) between the reference signal and all other signals must be corrected by dividing

	
  

32	
  

those differences by the frequency of the spectrometer (in MHz). Since this calculation
itself will produce very small values, the quotient is multiplied by one million. The
resulting value is known as the chemical shift (σ) and is reported in parts-per-million,
ppm, a unit that reflects the normalization by the MHz field strength as described
previously.
The chemical shift depends on the orientation of the sample to the magnetic field.
Since the samples used in our studies are in solution, the rapid tumbling of the molecules
leads to averaging of the chemical shifts thereby producing sharp resonance peaks. For
large molecules and molecular complexes, the rate of tumbling is slower which broadens
the resonance peaks observed and obscures the spectrum. Special conditions are met for
solid or semi-solid environments so as to collect spectra, as will be presented later in the
residual dipolar coupling discussion.
Again, high electron density increases shielding effect, such that the resonance
frequency is lower. The result is an upfield shift and a decrease in the chemical shift
towards the reference. Conversely, low electron density causes a downfield shift and an
increase in σ. Although chemical shift data is highly useful for examining protein
structure, chemical shift information is itself insufficient to determine protein structure.
The magnetic field range representing the resonances of protons in different
chemical environments is very small (see figure 2.3). Detecting a ppm difference can be
described as equivalent to detecting a one-millimeter difference in one-kilometer
distances. Current application of NMR involves strong magnets that allow observation of
proton resonances within most organic compounds between 0-14 ppm. Strong magnetic
fields and high sensitivity may produce signals that are distinct and well separated, signal
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detection and assignment in an unambiguous manner is very difficult without a numerical
locator. To overcome this issue special reference compounds are added to samples so as
to detect individual signals in a spectrum relative to the signal of the reference substance.
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Figure 2.3: Magnetic field range representing the resonances of protons
14 in
different chemical environments.

The frequency dependence of the absorption can be transformed into a time
dependence and vice-versa through Fourier transformation. In practice, a timed
radiofrequency pulse is applied to a sample to excite the observed nuclei and then watch
those nuclei return to their equilibrium population distributions in the magnetic field
(aligned with or against the external field). During the return to equilibrium, known as the
free induction decay (FID), an oscillating signal is produced which then decays over time
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but not before a measurable oscillating current is generated in a coil of wire. The time
domain data can be transformed into a frequency spectrum (figure 2.4) wherein the rate
of decay determines the peak width and the oscillation determines the frequency of the
peak. Multiple FIDS can be added to produce peaks with more signal-to-noise than a
single FID.
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Figure 2.4: Free induction decay of nuclei in a magnetic field.

2.2.1.3 Relaxation times and chemical exchange
During an experiment a rf pulse orients nuclei in a specific direction, with
precession about the direction of the external field. When the pulse ends, the nuclei in
the sample will return to the equilibrium conditions and populations (spin states)
associated with their environment. The rate at which each spin returns to its equilibrium
conditions depends on interactions with its neighbors (surrounding nuclear spins). This
rate also depends on fluctuations in the fields experienced as molecules tumble.
If a proton has a different chemical shift for two different states (represented by the
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following simple expression: A↔B) then the proton resonates at two different
frequencies. If the rate of exchange between the two states (chemical exchange) is very
slow, then two distinct, sharp peaks will be observed in the NMR spectrum. Conversely,
if the exchange occurs very rapidly, states A and B will interconvert repeatedly during
the test, and the two frequencies will average, thus causing observance of a single sharp
peak located at the weighted average between states A and B. This phenomenon indicates
the fraction of time spent in state A versus B; if the weighted average is closer to A than
B, then occupancy in state A is higher than that of state B and a peak will be observed
closer to the peak associated with state A. During intermediate chemical exchange, the
two lines observed in a slow exchange scenario will appear as if they had broadened and
coalesced into a single broad peak. However, even in the fast exchange regime, if a large
frequency difference exists between the two states, peak broadening may occur similar to
that of intermediate exchange.

2.2.1.4 Two-dimensional (2D) NMR
The preceding information mostly pertained to acquisition of a spectrum for a
specific nucleus (one-dimensional NMR- 1D NMR) by applying a frequency pulse and
analyzing the frequencies associated with a FID. In order to collect more accurate
structural information about molecules, utilizing multidimensional NMR becomes
necessary, whereby “cross-peaks” linking two resonances are identified. For the purposes
of the studies presented in this chapter, 1H and

15

N resonances are analyzed, through

space and through chemical bonds so as to identify the spatial relationship between those
nuclei.
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Whereas 1D NMR involves application of a single pulse, followed by FID and data
collection,

the

multidimensional

process

begins

with

application

of

several

radiofrequency pulses and time delays after which a FID is collected. The type of
experiment determines the number and length of the pulses and delays. This experiment
is repeatedly carried out and the signal collected is added. For the purpose of this
explanation, the qualitative details of the pulses and delays will be excluded.
Ultimately, the collected data for the 1H and

15

N resonances undergoes Fourier

transformation and becomes represented in a two-dimensional plot where the frequencies
for the two nuclei are plotted against one another. Nuclear spins of different non-bonded
nuclei (usually 1H-1H) may be measured through space as a result of interactions
(coherence transfer) between magnetic dipoles of the two nuclei. The through-space
interaction of magnetic dipoles is known as the Nuclear Overhauser Effect (NOE) and
analysis of the interactions is termed Nuclear Overhauser Effect SpectroscopY (NOESY).
NOE interaction between two magnetic dipoles varies as the inverse sixth power of the
distance between the two dipoles. Hence, only interacting nuclei very close to one
another (within approximately 5Å) will give rise to measurable NOEs.
Another informative process involves detection only of pairs on covalently linked
1

H and

15

N nuclei and is known as heteronuclear single quantum coherence (HSQC).

Each peak on an HSQC contour map represents a pair of covalently bound 1H-15N nuclei;
by convention, the x-axis represents the proton resonance frequency and the y-axis
represents the 15N. HSQC spectra provide highly informative data for assigning observed
resonances to specific amino acids in a protein structure, except proline, which has no
backbone N-H. HSQCs can provide further detail of protein structure from additional
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resonances provided by side-chains containing amides.
Structural determination from NMR data involves assigning resonances to specific
nuclei within the structure via analysis of 1H-15N (or other) HSQCs and sequential 1H-1H
NOEs. A three-dimensional model of the structure may be calculated through the use of
numerous constraints provided by distance information from NOEs and dihedral angle
information. The constraint information is then converted to a family of similar structures
that satisfy the experimental constraints.

2.2.1.5 Residual dipolar coupling
Protein structure determination has traditionally relied on the 1H-1H NOE and
various other constraints. Chemical shift analyses offer information pertaining to local
constraints on dihedral bond angles, whereas NOE data can relate atoms of a protein far
apart in the amino acid sequence, but close in space. Structural calculation often requires
a large amount of NOE data, but nevertheless can produce precise structural detail. In
certain situations, though, a lack of NOE cross-peaks reduces the ability to determine the
relative orientation of protein domains (e.g., non-globular or multi-domain proteins,
intermolecular complexes between proteins and between protein and DNA). Thus, a
demand exists for techniques that provide both local and long-range structural
information.
Interactions between pairs of magnetic dipoles in the presence of an external
magnetic field are referred to as dipolar couplings. This type of interaction is similar in
nature to a through-bond (scalar) interaction between nuclei, but unlike a scalar
interaction, dipolar couplings average to zero through normal rotational tumbling of
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molecules in solution. This phenomenon cannot be observed unless the rotational
movement of molecules in solution becomes restricted to a preferred orientation with
respect to the magnetic field. Introducing a weak degree of molecular alignment allows
for measurement of the residual 1H-15N dipolar-coupling interaction whose magnitude
depends on the degree of alignment and the angle formed between the internuclear vector
and the magnetic field. Hence, in this situation these couplings are referred to as residual
dipolar couplings (RDCs).
The information provided by RDCs directly relates to the distance between nuclei
and their relative orientation regarding a molecular reference frame defined by the nature
of the molecular alignment (see figure 2.5). Achievement of a weak degree of alignment
is critical to the acquisition of this information since the dipolar coupling interaction is
very strong; the effect can produce peaks wider than the spectrum normally collected. But
if only a small degree of alignment is introduced, then this effect shows up as a very
small chemical shift change (i.e., within a few Hertz) that compares to an otherwise very
sharp spectrum from a protein tumbling freely in solution. Therefore, the nature of the
alignment medium must allow for tuning, so that an appropriate degree of solute
alignment can be achieved. The alignment medium must also be relatively stable in
varying experimental conditions while minimizing adverse solute interactions that might
prompt unfavorable alignment conditions (e.g., interactions that adversely affect
rotational tumbling, thereby altering relaxation times).
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vectors, and thus the chemical bond orientation, in a protein that connect atoms
experiencing homonuclear (1H-1H) and heteronuclear (1H-15N, CαHα, CαC’, C’N)
dipolar coupling interactions. For this body of work, coupling was measured between the
amide 1H and

15

N atoms so as to measure the angle between the amide bond and the

alignment tensor, and thus, the relative orientations of NH bonds with respect to one
another (figure 2.6). The axis system created within the magnetic field is represented by
Axx, Ayy, and Azz in figure 2.5 and Sxx, Syy, and Szz in figure 2.6. The angles displayed in the
figure define the orientation of the vector with respect to the magnetic field. The NMR
pulse program most commonly used to measure the one-bond amide dipolar coupling
represents a modification of the 15N-HSQC. In this type of modified HSQC, the magnetic
dipole coupling between the 1H and 15N is allowed to evolve as the 15N chemical shift is
observed. Measurement of the amide dipole coupling depends, in part, on the distance
between the bonded nitrogen and hydrogen atoms. Since this distance is known, the
RDC measurement can be used to establish the angle between the N-H bond and the
alignment tensor, which then identifies the relative orientations of the amide bonds with
respect to each other, as seen in figure 2.6.
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Dipolar couplings as a probe of molecular dynamics and structure in solution Tolman
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structures, especially when few NOEs are available. For RDC-derived structures, the Q
factor represents structure quality. That is, the agreement between the calculated structure
and the experimental data; in this sense the Q factor is analogous to the R factor used in
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x-ray crystallography. Values of approximately 25% represent high-resolution structural
refinement.

2.3 EXPERIMENTAL PROCEDURES

2.3.1 Purification of proteins and DNA:
The methylcytosine-binding domain of MBD3 (amino acid residues 1-70) was
cloned, expressed and purified as previously described for cMBD2 (18). 17-bp and 27-bp
complementary

oligonucleotides

(Table

1)

were

purchased

(Integrated

DNA

Technologies), annealed and purified as previously described (18). The sequences were
derived from the p16INK4a promoter known to be a native target sequence for MBD2 (5).

2.3.2 NMR spectroscopy:
Purified protein was combined with 10% excess purified dsDNA and buffer
exchanged into 10 mM NaPO4, pH 6.5, 1mM dithiothreitol, 10% 2H2O and 0.02%
sodium azide and concentrated to 0.2-1.0 mM. NMR spectra from standard experiments
for resonance assignments, distance and torsional angle restraints were collected on a
Bruker Avance III 700 MHz instrument. Data were processed using NMRPipe (19) and
analyzed with CcpNmr (20). Residual dipolar couplings were measured for complexes
containing 2H,

13

C,

15

N labeled protein using standard IPAP experiments and samples

aligned by adding ~12mg/mL Pf1 bacteriophage (Asla Biotech, Ltd.). For each aligned
sample, a 1D 2H spectrum of 2H2O was collected and the deuterium quadrupole splitting
measured. When comparing RDC values between samples, the observed RDC values
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were normalized to an effective deuterium quadrupole splitting of 10 Hz.

2.3.3 Structure Calculations:
The structure of the MBD3 MBD was calculated by simulated annealing as
implemented in the Xplor-NIH software package (21) and based on NOE derived
distance constraints, torsion angle restraints, and residual dipolar couplings as well as a
torsion angle database potential of mean force (22) and a quartic van der Waals repulsion
term for non- bonded contacts (23). Backbone torsional angle restraints were derived
from chemical shifts using the TALOS+ software (24) and hydrogen bond distance and
angle restraints were introduced based on backbone torsional angles and characteristic
NOE patterns.

2.3.4 Binding affinity:
Binding affinities were determined by surface plasmon resonance analysis on a
Biacore T100 system (GE Healthcare) as described previously (18). The binding affinity
was determined from steady state analysis of the SPR relative response at varying
concentrations of protein. As previously shown, the maximum steady state response
(Rmax) in SPR depends on stoichiometry (n) of binding (25). Prior to fitting, the steady
state response at each protein concentration (RA) was normalized (Rnorm) to the total DNA
immobilized (Rl) and molecular weights of the DNA and protein (MWL and MWA,
respectively).
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the steady state response at each protein
concentration (RA) was normalized (Rnorm) to the
total DNA immobilized (Rl) and molecular
weights of the DNA and protein (MWL and MWA,
respectively).
Rnorm =

RA
⎛ MWA ⎞
RL i ⎜
⎝ MWL ⎟⎠

(1)

Final data analysis, plotting, and curve fitting were
Final data analysis, plotting, and curve fitting
performed with pro Fit software (QuantumSoft).
(QuantumSoft).

RESULTS
Solution structure of the MBD3 MBD is nearly
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2.4.1 Solution structure of the MBD3 MBD is nearly
3! identical to that of MBD2.
We determined the solution structure of the MBD from MBD3 (amino acids 1-70)
bound to a 17-bp dsDNA with a central hydroxymethylated CpG dinucleotide. The
structure was calculated based on 528 NOE derived distance constraints, 120 dihedral
angle restraints, and 53 residual dipolar coupling restraints (Table 2.1). The overall
protein structure is well defined (Fig. 2.7A-B) with average pairwise root mean square
deviations (RMSD) of 0.7±0.1 Å (backbone) and 1.2±0.1 Å (all heavy atoms) for ordered
regions (residues 6-23,34-71). As expected, the fold is very similar to that of chicken
MBD2 (cMBD2; RMSD=2.0±0.1 Å) for the same ordered regions (Fig. 2.7D) (18).
As with all MBD proteins studied to date, the topology of the MBD comprises a
four-stranded β-sheet followed by a single α-helix and a C-terminal loop. The central two
strands of the β-sheet (β2 and β3) form a long finger-like projection that can extend down
and across the major groove of DNA to make base specific contacts. The most notable
difference between the cMBD2 and MBD3 structures is that the loop connecting the long
fingerlike projection is not as well ordered in MBD3 (residues 24-33, Fig. 2.7A,C) with
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an RMSD of 1.7±0.5 Å (backbone) as compared to cMBD2 with an RMSD of 0.9±0.3 Å.
Residues at the base of this loop form critical DNA specific contacts and a hydrogen
bond network that stabilizes the interaction with the methylated CpG dinucleotide (Fig.
2.7E).
Predicting backbone order parameters (S2) based on chemical shifts using the
random coil index (RCI) method (24, 26) confirms that this loop is less well ordered in
MBD3 (Fig. 2.8). The difference in predicted S2 between complexes and shows that
residues 24-33 become progressively more ordered between the MBD3:hmCpG,
MBD3:mCpG and cMBD2:mCpG complexes, respectively. Thus in the absence of a
methylation-specific binding mode, the loop connecting the central two β-strands is more
flexible.
Filtered intermolecular NOE spectra did not contain NOE crosspeaks, which is
consistent with the observed line broadening for residues at the DNA interface and the
overall lower affinity of MBD3 for DNA and suggests non-specific protein-DNA
interaction with dynamic exchange between binding sites. Based on subsequent analyses
that indicate MBD3 preferentially localizes to methylated sites, we collected filtered
NOE spectra for MBD3 bound to methylated DNA (mCpG). Likewise, we did not detect
any intermolecular NOE crosspeaks with methylated DNA indicating that MBD3
exchanges among different binding modes whether on methylated or hydroxymethylated
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The dynamic distribution of MBD3 on DNA
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FIGURE 2.7: Solution structure of MBD3 methyl binding domain bound to hydroxymethylated
DNA. (A) Stereo ribbon diagram (blue) of the MBD3 solution structure is shown for the ensemble of
twenty calculated structures (PDB ID: 2mb7).
The loop
Figure
1 connecting β2 and β3 (residues 24-33) is
highlighted in light blue. (B) Ribbon diagram of the lowest energy solution structure is shown with key
contact and chemical shift reporter residues depicted in sticks. (C) Per residue root mean standard
deviation (RMSD) for backbone atoms is plotted for the solution structure ensemble of MBD3 (blue) and
for the solution structure ensemble of cMBD2 (red) previously reported (PDB ID: 2ky8).(18) (D) The best
fit protein alignment of the solution structures of cMBD2 (green) and MBD3 (blue) MBD is shown bound
to the methylated DNA from the cMBD2:dsDNA solution structure (PDB ID: 2ky8). (E) Diagram
highlighting the cMBD2 hydrogen-bonding network while bound to methylated DNA and with key
residues depicted as sticks. Structure diagrams were generated using the Pymol program (Delano
Scientific LLC).

DNA. Given the absence of informative intermolecular NOEs we did not determine a
solution structure of the protein-DNA complex. Importantly, we noted that chemical
shifts of MBD3 bound to hmCpG (discussed in detail below) are more similar to MBD3
on unmethylated DNA than methylated DNA, which led us to compare spectra of MBD3
on different DNA molecules to probe both methylation-specific and non-specific DNA
association.
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15

FIGURE 2.8: Methyl-specific binding mode stabilizes a dynamic loop in MBD3. (A) Ribbon diagram
of the MBD3 solution structure is shown and colored based on order parameters predicted from chemical
shift index (S2 – shading from blue to red reflects low to high). (B) The predicted order parameters (S2)
are plotted for the MBD3:hmCpG (black), MBD3:mCpG (blue dotted), and cMBD2:mCpG (red)
complexes. (C) Bar plots are shown for the difference in order parameters (ΔS2) between the
cMBD2:mCpG complex and MBD3:mCpG (black) and MBD3:hmCpG (gray) complexes. The loop
connecting β2 and β3 (residues 24-33) is highlighted in light yellow in plots (B) and (C).

2.4.2 MBD3 spends a significant portion of time on methylated sites.
As first described for MeCP2 (27), and later described for cMBD2, (18) a pair of
highly conserved arginine residues in MBD proteins form bi-dentate hydrogen bonds
with the symmetrically opposed guanine bases of an mCpG dinucleotide (Fig. 2.7E). The
aliphatic portion of each arginine packs against the methyl group of the neighboring

	
  

48	
  

methylcytosine. Given that an unmethylated CpG contains symmetrically opposed
guanines, we hypothesized that MBDs should still recognize the CpG dinucleotide, but
with lower affinity. Even though MBD3 binds DNA with lower overall affinity and
shows less selectivity for methylated DNA, the critical arginine residues are conserved
and could provide sequence specific recognition of CpG dinucleotides.
In

15

N-HSQC spectra, we noted that several crosspeaks that showed unusual

chemical shifts for cMBD2:mCpG did not show the same chemical shifts for
MBD3:hmCpG (Fig. 2.9B). In particular, the 1Hε of R24, which forms a sidechain
hydrogen bond with D32 and is shifted far downfield (9.5ppm) in cMBD2:mCpG, is only
shifted to 7.5ppm in MBD3. Likewise, G27 is shifted upfield in

15

N to 102ppm in

cMBD2:mCpG, but not to the same degree in MBD3:hmCpG (105ppm), and finally A30
is shifted upfield in 1H to 6.8ppm in cMBD2:mCpG but only 7.6ppm in MBD3:hmCpG.
We hypothesized that these large chemical shift changes reflect a difference
between methylation-specific and non-specific binding modes. R24 and D32 are
positioned at the N and C terminus of the poorly structured loop in MBD3, while A30
and G27 also fall within this same loop. Methylation-specific binding stabilizes the
R24:D32 H-bond and the loop containing G27 and A30. To test this hypothesis, we
compared HSQCs for MBD3 bound to a DNA sequence with three CpG dinucleotides in
which the central CpG is methylated (mCpG), hydroxymethylated (hmCpG), or
unmethylated (CpG(x3)), as well as similar DNA sequences with only one (CpG(x1)) or
no CpGs (CpG(x0)) (Table 2.2).
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The dynamic distribution of MBD3 on DNA
Table 2. NMR and refinement statistics. The number and type of structural constraints as well as the
final refinement statistics are presented for the solution structure of MBD3 bound to hydroxymethylated
DNA.
Protein
NMR distance and dihedral constraints
Distance constraints
Total NOE
Intra-residue
Inter-residue
Sequential (|i – j| = 1)
Medium-range (|i – j| ≤ 4)
Long-range (|i – j| > 5)
Hydrogen bonds
Total dihedral angle restraints
φ
ψ
χ1
Total RDCs
NH
Q%
NH
Structure statistics
Violations (mean and s.d.)
Distance constraints (Å)
Dihedral angle constraints (º)
Max. dihedral angle violation (º)
Max. distance constraint violation (Å)
Deviations from idealized geometry (mean and s.d.)
Bond lengths (Å)
Bond angles (º)
Impropers (º)
Average pairwise r.m.s. deviation* (Å)
Heavy
Backbone
Ramachandran plot summary for ordered residues
Most favored regions
Additionally allowed regions
Generously allowed regions
Disallowed regions

528
102
155
111
160
32
120
54
54
12
53
7.0
0.018±0.003
0.4±0.1
4.8
0.48
0.04±0.01
0.69±0.002
2.01±0.006
1.2±0.1
0.7±0.1
92.4%
7.4%
0.2%
0.0%

*Pairwise r.m.s. deviation and s.d. from the mean was calculated among 20
lowest energy (out of 50) refined structures for ordered residues (6-23, 34-71).

Table 2.1: NMR and refinement statistics. The number and type of structural
constraints as well as the final refinement statistics are presented for the solution
structure of MBD3 bound to hydroxymethylated DNA.
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We found that the chemical shifts of these reporter resonances fall on a line
between extrema represented by cMBD2:mCpG and MBD3:CpG(x0). Importantly, the
peak position for each of the reporter resonances falls at the same fractional distance
between these extrema (Fig. 2.9B), shifting toward the position in the cMBD2:mCpG
complex as the number of unmethylated CpG sites increases and with the addition of a
methylated CpG. These observations strongly indicate chemical shift averaging between
two binding modes (28) reflective of fast exchange between methylation-specific and
non-sequence specific interaction with DNA. Furthermore, the chemical shift changes are
consistent with preferential localization at the CpG and mCpG sites.
Using cMBD2 as representative of the methylation-specific binding mode could
introduce structural and primary sequence differences that affect observed chemical
shifts. Therefore, we sought to generate an MBD3 MBD that binds with high selectivity
for mCpG, which would allow us to evaluate chemical shift changes for more backbone
resonances with fewer confounding sequence variations. Previous studies have
established that the lack of mCpG specificity for MBD3 reflects two amino acids (H30
and F34) that differ from other MBD proteins (K32 and Y36 in cMBD2) (4, 5). We
introduced the H30K, F34Y double mutation into MBD3 (MBD3KY) and, as expected,
this mutant bound with higher affinity and selectivity for mCpG comparable to cMBD2
(Fig. 2.13, Table 2.3). Each of the reporter resonances now show chemical shifts that are
very similar to those of the cMBD2:mCpG complex confirming that the unique chemical
shifts do reflect a methylation-specific binding mode.
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TABLES

Table 1. DNA sequences. The length and nucleotide sequences are given for the different
dsDNA molecules used for MBD2 and MBD3 binding studies.
Name
mCpG
hmCpG
CpG(x3)
CpG(x1)
CpG(x0)
mCpG27
mCpG10

Length
(bp)
17
17
17
17
17
27
10

Sequence
GAGGCGCT(mC)GGCGGCAG
GAGGCGCT(hmC)GGCGGCAG
GAGGCGCTCGGCGGCAG
GAGGCCCTCGGGGGCAG
GAGGCCCTCTGGGGCAG
GAGCTAGAGCGCT(mC)GGCGGCGCCAGGC
GGAT(mC)GGCTC

Table 2.2: DNA sequences. The length and nucleotide sequences are given for the different
dsDNA molecules used for MBD2 and MBD3 binding studies.

To further explore the chemical shift changes associated with the different binding
modes, we assigned the backbone resonances (15N, 1H) for MBD3 bound to mCpG or
CpG(x3) and MBD3KY bound to mCpG. In Figure 3A, the chemical shift distances are
plotted for backbone resonances between the different complexes. The largest chemical
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despite a lack
DNA as well as for MBD3KY bound to
of a strong global binding affinity preference for
DNA. As can be seen in Figure 4, t
mCpG DNA, MBD3 still spends a significant
1

and DNA bound, we find that MBD3 spends approximately 43% (±5%) of the time on
the mCpG site (Fig. 2.9B).
These data further indicate that, despite a lack of a strong global binding affinity
preference for mCpG DNA, MBD3 still spends a significant proportion of time on
methylated sites. To confirm that this finding was not the result of very weak binding
with chemical shift averaging between DNA bound and free MBD3, we compared
HSQCs for 600µM and 300µM samples of protein on DNA. The peaks for each reporter
residue show nearly identical chemical shifts at both concentrations (Fig. 2.11B),
indicating that the observed chemical shift changes of the reporter residues were not the
result of exchange between bound and free states but instead represent averaging between
different bound states. The observed differences in chemical shift represent changes in
the binding distribution on DNA, not changes in the distribution between bound and free
states.
We developed a statistical-mechanical model to describe the distribution of MBD3
on methylated DNA (Fig. 2.9C) in which the partition function comprises a sum of
Boltzmann factors (e-E(i)/kT) for methylation-specific and non-specific binding modes, ΔE
is the difference in energy between binding modes and N is the number of non-specific
sites. The additional methylation- specific interactions formed by MBD2 lead to a larger
ΔE thereby increasing ρm and the relative selectivity for mCpG. Without these
interactions, MBD3 shows a smaller ΔE, ρm is reduced but still non-zero, and MBD3
distributes unevenly between mCpGs and unmethylated sites. Figure 2.9C depicts a
simplified structural model of this distribution in which the MBD3 structure was docked
onto the 17-bp DNA fragment at the centrally methylated mCpG (red) as well as four
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“non-specific” binding sites (blue). The statistical model further indicates that localizing
to a mCpG depends on the number of non-specific sites available (N), and therefore the
length of DNA. We tested this latter prediction by comparing chemical shifts for the
reporter residues of MBD3 on 10, 17, and 27-bp DNA with a single mCpG (Fig. 2.9D).

The dynamic distribution of MBD3 on DNA

Indeed, we found that increasing DNA length results in chemical shift changes for G27
and A30 toward the unmethylated binding mode.
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FIGURE 2.9: Preferential localization of MBD3 to mCpG sites. (A) Bar plots show the chemical shift
Figure(B)
3 An overlay of 15N-HSQC spectra are shown for key
distances between MBD3:dsDNA complexes.
reporter residues of MBD3 bound to CpG(0x), CpG(1x), CpG(3x), mCpG and hmCpG as well as
MBD3KY and cMBD2 bound to mCpG. (C) The derivation of a simple statistical mechanical model for
the distribution of MBD3 on mCpG (top) is shown with a mixed rendering diagram (bottom) depicting
MBD3 docked onto a methylated site (red) as well as four non-methylated sites (blue) of the mCpG DNA.
Arrows indicate rapid exchange between these binding modes. (D) Overlay of 15N-HSQC spectra are
shown for key reporter residues of MBD3 and MBD3KY while bound to DNA of varying lengths.
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minimized when ρm is 0.37. Plotting observed 1DNH,MBD3:mCpG versus predicted at ρm =
0.37 shows good agreement with tight clustering around y=x (Fig. 2.10D). Therefore,
using RDCs as an independent measure of methylation selectivity, we find that MBD3
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spends approximately 37% of the time on the methylated binding site, which agrees
within experimental error with the results from chemical shift analysis.
The residual dipolar couplings for each complex were fit to the solution structure of
MBD3 bound to hmCpG using singular value decomposition as implemented by the
PALES software (30). Despite the differences in RDCs between complexes, each data set
fit quite well to the MBD3 structure with Q factors of 19.9%, 23.1%, and 25.9% for the
MBD3:mCpG, MBD3:CpG(x3), and MBD3KY:mCpG complexes, respectively (Fig.
2.10E). Therefore, the change between methylated and non-specific binding modes does
not involve backbone structural changes. The observed chemical shift changes likely
reflect a stabilization of the dynamic loop between β2 and β3 but without significant
structural rearrangements.
1
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FIGURE 2.10: MBD3 localizes to
methylated
DNA
sites
without
significant conformational change. A
comparison of measured 1DNH RDCs
normalized to 2H2O quadrupole splitting of
10 Hz are plotted for (A) MBD3:mCpG vs
MBD3:CpG(x3) and (B) MBD3:mCpG vs
MBD3KY:mCpG complexes. Red ovals
highlight those values that fall of the line
of identity (gray line). (C) The sum of
squared residuals (SSR) is plotted as a
function of ρm (Eq. (3)). The SSR is
minimized (red circle and arrow) at 37%
mCpG bound (ρm = 0.37). (D) Plotting
1DNH RDCs for MBD3:mCpG observed
vs. predicted with ρm = 0.37 ((3)) shows
good agreement with tight clustering
around y = x. (E) The measured 1DNH
RDCs for each complex (MBD3:CpG(x3),
MBD3KY:mCpG, and MBD3:mCpG, left
to right plots, respectively) were fit to the
solution structure of MBD3 by SVD and
the observed vs. predicted values plotted.
The Q factors and correlation coefficients
show good agreement with the solution
structure indicating that the backbone
structure of MBD3 does not change
between complexes.
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MBD3:mCpG at 600 µM (blue) and 300
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2.4.4 MBD2 and MBD3 distribution is influenced by DNA methylation status and CpG
density:
In contrast to MBD3, MBD2 appears to spend most of its time on the methylated
site (Fig. 2.12A). The chemical shifts for reporter residues in MBD2 represent the
extrema for the complexes studied. As shown in Figure 6B, these peaks do not change
with increasing DNA length, indicating that a large ΔE dominates the fraction bound to
the methylated site and ρm ≈ 1 (Fig. 2.9C). The higher affinity and methylation selectivity
of MBD2 results in exclusive occupancy of mCpG.
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Comparing spectra of MBD2 and MBD3 when bound to the unmethylated
oligonucleotides CpG(x0), CpG(x1) and CpG(x3) reveals that the reporter resonances
shift towards the methylation-specific state with increasing numbers of CpGs (Fig. 2.9B
and 2.13A). This finding indicates that both MBD2 and MBD3 localize to sites of
increased CpG density. MBD3 shows relatively small chemical shift changes when
bound to CpG(x3) as compared to CpG(x0), consistent with localizing to a CpG
dinucleotide approximately 9% (±3%) of the time. MBD2 shows a pronounced difference
between CpG(x0) and CpG(x3) (Fig. 2.12A) showing that MBD2 preferentially localizes
to CpG dinucleotides approximately 33% (±11%) of the time. The reporter resonances
also indicate that MBD2, but not MBD3, tends to localize to hmCpG and exhibits higher
affinity for these sites (Fig. 2.12A, Table 2.3). To test whether MBD3 could influence
how MBD2 distributes on unmethylated CpGs, we added equimolar MBD3 to

15

N-

MBD2 bound to CpG(x3) and found that the reporter peaks shifted towards those of the
non-specific binding mode (Fig 2.12A). This finding shows that despite relatively weak
dynamicondistribution
overall binding affinity, MBD3 can modulate the distribution The
of MBD2
CpG sites,of MBD3 on DNA

shifting MBD2 towards the non- specific binding mode.
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FIGURE 2.12: MBD2 distribution
is influenced by DNA methylation
status and CpG density. (A) An
overlay of 15N-HSQC spectra for
key reporter residues of MBD2
bound to CpG(0x), CpG(1x),
CpG(3x) +/- MBD3, mCpG and
hmCpG, shows that cMBD2
preferentially localizes to DNA with
mCpG, hmCpG and multiple CpG
sites, and that localization is
modified by the presence of
equimolar MBD3. (B) An overlay of
15
N-HSQC spectra cMBD2 bound to
mCpG DNA of varying lengths
confirms that cMBD2 strongly
prefers mCpG sites.

2.4.5 Global binding affinity does not reflect localization preferences on DNA:
Binding affinities for each of the methylated and unmethylated sequences
investigated were determined by steady-state analysis of surface plasmon resonance data,
as described previously (18). To allow for direct comparison of binding stoichiometry,
we normalized the relative steady-state response to the amount of DNA coupled to the
sensor chip such that the maximum steady-state response reflects the number of binding
sites on the DNA (25). As can be seen in Fig. 2.13 and Table 2.3, both cMBD2 and
MBD3KY bind mCpG DNA with high affinity and stoichiometry of approximately one
(KD = 105 ± 7 nM and113 ± 11nM and Rmax = 0.83 ± 0.01 and 0.98 ± 0.02, respectively).
Both bind unmethylated DNA with much lower affinity and high stoichiometry (KD = 74
± 4 µM and 17 ± 2 µM and Rmax = 4.8 ± 0.1 and 2.1 ± 0.1, respectively) indicative of a
high degree of methylation selectivity.
While NMR analyses indicate MBD3 binds DNA with sufficient affinity to be fully
bound at 300µM concentration (Fig. 2.11B), solubility limits of the isolated protein
preclude accurate determination of binding constants by surface plasmon resonance. The
qualitative results of these studies, however, are very similar to those reported previously
by Hashimoto et al. (15) who determined DNA binding affinity for full-length MBD3 by
fluorescence anisotropy. In those previous studies, MBD3 bound with similar low affinity
to unmethylated and hydroxymethylated DNA and with a small but weak preference
(approximately five-fold) for methylated DNA. The current SPR data indicates a small
preference for mCpG as well (Fig. 2.13).
Likewise, cMBD2 shows similar low affinity and high stoichiometry when binding
to hydroxymethylated and unmethylated DNA with 0-3 CpG dinucleotides (Fig. 2.13 and

	
  

59	
  

Table 2.3). Therefore, global binding analysis reveals a marked preference for mCpG by
cMBD2 and MBD3KY but only weak and non-specific binding for all other complexes.
These findings agree with several previous DNA binding analyses of MBD proteins (4, 5,
15, 18).
The dynamic distribution of MBD3 on DNA
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FIGURE 2.13: MBD2 and
MBD3 localization does not
translate into a global binding
affinity preference. Steady state
surface
plasmon
resonance
measurements are shown for
MBD3 (top panel) and cMBD2
(bottom panel) binding to
immobilized double stranded
oligonucleotides of varying CpG
content and methylation status.
The steady-state response was
normalized to the amount of DNA
immobilized (Eq. (1)) such that
the maximum response reflects
the stoichiometry of binding (n).
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Table 3. Binding affinity. The dissociation constant (KD), Rmax, and Chi2 are given for different
protein and DNA complexes as determined by steady state analysis of surface plasmon
resonance studies.
Protein

DNA

KD (µM) ± SE

Rmax*

Chi2 (x10-3)
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MBD3
mCpG
54 ± 7
3.2
25
MBD3
CpG(x3)
n.d.**
MBD3
CpG(x1)
n.d.
MBD3
CpG(x0)
n.d.
MBD3
hmCpG
n.d.
MBD3KY
mCpG)
0.13 ± 0.01
1.0
2.6
MBD3KY
CpG(x3)
17 ± 2
2.1
1.8
MBD2
mCpG
0.11 ± 0.01
0.8
1.0
MBD2
CpG(x3)
74 ± 4
4.8
3.8
MBD2
CpG(x1)
78 ± 7
4.8
7.2
MBD2
CpG(x0)
68 ± 3
5.4
5.9
MBD2
hmCpG
54 ± 8
4.3
51
*Normalized such that Rmax reflects stoichiometry (n)
**Weak binding and solubility limits preclude accurate determination of
binding affinity.

Table 2.3: Binding affinity. The
dissociation constant (K D), Rmax,
and Chi2 are given for different
protein and DNA complexes as
determined by steady state
analysis of surface plasmon
resonance studies.
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2.5 DISCUSSION

Although it has been established that MBD3 binds DNA with lower affinity and
much less specificity for mCpG dinucleotides than MBD2, the functional role of MBD3
has not been well defined. Based on NMR structural, chemical shift, and residual dipolar
coupling analyses, we have demonstrated that MBD3 binding to methylated DNA can be
described by an ensemble of methylation-specific and non-specific binding modes and
that MBD3 preferentially localizes, albeit weakly, to methylated sites. In contrast to
MBD2, MBD3 does not distinguish between hydroxymetylated and unmethylated DNA
but does show a slight preference for DNA with multiple CpG dinucleotides.
A similar chemical shift analysis of cMBD2 showed that cMBD2 localizes almost
exclusively to the methylated sites when present. Even on unmethylated DNA, cMBD2
preferentially localizes to CpG dinucleotides, especially as the number of available CpGs
increases. Surprisingly, cMBD2 more avidly localized to a hydroxymethylated than an
unmethylated site. Taken together, these findings lead to a model in which both MBD2
and MBD3 preferentially localize to DNA with multiple CpGs while MBD2 more
exclusively localizes to mCpGs.
Our studies lead to several novel observations and hypotheses. First, the differences
in DNA binding between MBD3 and MBD2 reflect a change in the degree of selectivity
for mCpG, not absolute differences in binding specificity. As we hypothesized, both
MBD2 and MBD3 show a weak preference for CpG dinucleotides even the absence of
methylation; however, MBD2 shows a much greater selectivity for mCpG than MBD3.
These preferences are not necessarily apparent by global binding analyses but instead are
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reflected in the partitioning between methylation-specific and non-specific binding
modes on DNA, observed via NMR analysis.
The observed changes in the NMR spectra arise from changes in the distribution of
bound states, not from changes in the distribution between bound and free states. In
addition, the preference, though weak, for multiple CpG sites within the relatively small
17-base pair oligonucleotide used in these studies correlates with the whole genome
analyses that show MBD2 and MBD3 localize to CGIs. Given that a CGI contains 1001000s of CpG dinucleotides, even a relatively small preference would lead to fairly
strong localization at such sites. Furthermore, these findings correlate with the
observations that both MBD2 and MBD3 are found at unmethylated CGIs, whereas
MBD2 binds with much greater affinity and likely excludes MBD3 from methylated
CGIs. Finally, these studies clearly indicate that MBD3 does not exhibit a binding
preference for or a structural recognition of hmCpG DNA. From the standpoint of
MBD3, hydroxymethylation is functionally equivalent to demethylation.
Genomes containing both MBD2 and MBD3 proteins emerge at the same time as
the vertebrate methylation pattern, which includes largely unmethylated CGIs. This
concurrence along with the preceding characterization of DNA binding by MBD3 leads
us to speculate that MBD3 plays an important role in regulating genes with unmethylated
CGIs. One possibility these studies raise is that MBD3 helps counterbalance the tendency
of MBD2 to preferentially localize to CpG dinucleotides, and consequently to aberrantly
silence the associated genes, by competing with MBD2 at unmethylated CGIs.
We found that MBD3 does modify the distribution of MBD2 on DNA such that
MBD2 spends less time on CpG sites. Thus MBD3 could help prevent gene silencing by

	
  

62	
  

MBD2 at unmethylated gene promoters and enhancers depending on the relative
concentration of the two proteins and cellular context. Indeed, recent studies have shown
that knockdown of MBD3 can lead to decreased gene expression (16, 17).
Mammalian cells express multiple MBD proteins as well as different isoforms of
individual MBDs. Different splice variants as well as distinct genes encode for MBD2
and MBD3 proteins, some of which lack the DNA binding domain itself. Here, we have
studied the solution structure and DNA binding of MBD3 by NMR. Chemical shift
analyses indicate that MBD3 recognizes and preferentially localizes to both mCpG and
CpG sites but not to the same extent as MBD2. Single amino acid differences dictate the
degree to which these proteins localize on mCpG sites. Importantly, these binding
characteristics do not necessarily lead to changes in global binding affinities but rather
correlate with localization of MBD2 and MBD3 to CGIs in whole cells. Hence, a number
of different NuRD complexes can be formed that show varying degrees of DNA
methylation selectivity and provide distinct functional roles. For MBD3, these functional
differences appear to reflect subtle distinctions in the behavior of the MBD when bound
to methylated and unmethylated DNA. Indeed, recent studies have shown that MBD3NuRD may serve multiple roles in modifying expression for both active and silent genes
through localization at promoters, gene bodies, and enhancers of active genes (31).
Therefore, these data establish a structural basis for the relative distribution of MBD2 and
MBD3 on genomic DNA and help explain their observed occupancy at CpG-rich
promoters.
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Chapter 3- Sponge MBD2 targets methylated DNA and
recruits NuRD components

3.1 ABSTRACT

Invertebrates and vertebrates exhibit substantial variation in DNA methylation
patterns. Methyl-cytosine binding domain (MBD) family members also vary in both
types of organisms. Whereas invertebrates are known to express only MBD2/3 homologs,
vertebrates harbor several MBD family members. Expansion of the MBD family appears
to have accompanied the invertebrate-vertebrate transition, though MBD2 preference for
methylated DNA has largely been retained throughout the animal lineage. Sponges
represent the base of the animal kingdom, and recent genomic analyses of sponges
Amphimedon queenslandica and Ephydatia muelleri indicate the presence of individual
genes for MBD2/NuRD complex members; no other MBD family members have been
identified in sponge genomes. We questioned whether or not sponge MBD2 targets the
NuRD complex to methylated DNA, like other metazoan orthologs, and assessed the
ability of MBD2 to select for methylated DNA and recruit NuRD components in the
freshwater sponge Ephydatia muelleri. We observed that Ephydatia MBD2 binds
methylated DNA with approximately 150-fold selectivity over unmethylated, compared
to a 430-fold preference for methylated DNA exhibited by human MBD2. The Ephydatia
MBD2 and p66α coiled-coil regions display low identity with human and little preformed helical content, but nevertheless, the sponge proteins possess nearly all amino
acid residues necessary for high affinity binding observed by the human MBD2-p66α
coiled-coils. Despite this similarity, the sponge coiled-coils bind weakly, though
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interactions between the sponge and human coiled-coils occur much more avidly.
Further, the Ephydatia MBD2 p55BR recruits human MTA2, but not human NuRD
components HDAC 1/2 and Rbap 46/48, unlike the human p55BR, which can recruit all
three NuRD core components. Finally, RNAi-induced knockdown of Ephydatia MBD2
results in a low-growth phenotype marked by failure to form structures associated with
early development in sponges. Taken together, these data suggest that sponges likely
likely harbor a methylation-specific NuRD complex similar to that found in humans and
thus have the capacity to carry out sophisticated epigenetic processes, including targeted
chromatin remodeling, that likely pre-date sponge emergence.

3.2 INTRODUCTION

Patterns of DNA methylation changed during the transition from invertebrate to
vertebrate life. While invertebrate methylomes often harbor “mosaic” methylation
patterns in gene bodies, vertebrates tend to show a global methylation pattern that often is
observed in promoter regions and gene bodies (1) and appears to correlate with an
expansion of the DNA methyltransferase and methyl-cytosine binding domain (MBD)
families (2).
DNA methylation represents an abundant epigenetic mark in vertebrates, while
many invertebrates lack detectable cytosine methylation (1). Notably, this is the case for
several invertebrate organisms, including several invertebrate model organisms (e.g.,
yeast, fruit fly, and worm) (3). Most tested invertebrates, though, show mosaic
methylation. But, the sea squirt Ciona intestinalis represents the only invertebrate for
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which a detailed map of this pattern has been determined (4). Nevertheless, research
continues to demonstrate the pervasiveness of cytosine methylation as an evolutionarily
ancient genomic regulatory mechanism. Further, given that DNA methylation is a
mechanism for regulating endogenous gene expression and possibly reducing
transcriptional noise, research suggests that a reduction in unnecessary gene expression
may have permitted the increase in gene number and in complexity that characterizes
animals (5).
Sponges represent the most ancient and primitive animal (6) and share with fungi a
common evolutionary history in that their last common ancestor was likely a flagellated
protist similar to the choanoflagellate (7). Despite their distinct morphological separation
from other animals, studies of sponges have shed light on the molecular evolution of
animals. Like higher animals, the sponge genome harbors genes crucial for growth and
differentiation, cell-cycle regulation, cell-cell adhesion, and self versus non-self
recognition (8). Sponges also share in common with animals numerous transcription
factor, sensory transduction, and cell adhesion genes (9).
However, little study of Poriferan epigenetic regulation has been carried out.
Although the recently sequenced Amphimedon queenslandica genome highlights
numerous molecular framework similarities between sponges and other animals, much is
still unknown regarding the epigenetic machinery in place at the dawn of metazoans.
Given the phylogenetic position of sponges at the base of the animal kingdom,
elucidating their epigenetic machinery will better clarify epigenetic regulation carried out
by the last common ancestor to all animals. This information will tell us more about the
origins of the epigenetic machinery present in vertebrates. Characterizing these features
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throughout animal developmental history could be highly useful regarding study of
human epigenetics.
Vertebrates harbor a divergent family of methyl-cytosine binding domain (MBD)
proteins critical for reading DNA methylation as an epigenetic mark. MBD family
members include MeCP2 and MBD1-4. MBD1, MBD2, MBD3 are one sub-family:
MBD1 and MBD2 prefer methylated DNA while MBD3 does not, at least not to the same
extent. MBD4 and MeCP2 represent a second, more recent sub-family containing an
insertion that leads to a longer alpha helix and larger hydrophobic core. MeCP2 is
important for neurologic development while MBD4, through its associated glycosylase
domain, repairs TpG/CpG mismatches (4).
MBD2 can be found throughout the animal kingdom and its structural components
primarily consist of a methyl-cytosine binding domain followed by a region implicated in
binding the RbAp46/48 homolog p55 (p55-binding region; p55BR) (10) and a C-terminal
coiled-coil (CC) region. MBD2 targets methylated DNA with high affinity through
highly conserved DNA contacting amino acid residues located within its methyl-cytosine
binding domain.
MBD2 associates the ATP-dependent nucleosome remodeling and deacetylase
complex (NuRD) (11). Six core proteins comprise the complex and constitute its ability
regulate gene expression at the chromatin level: MBD2 or MBD3; histone deactylase
(HDAC) 1 or HDAC2; chromatin remodeling enzyme Mi-2α (CHD3) or Mi-2β (CHD4);
p66α (GATAD2A) or p66β (GATAD2B); metastasis-associated (MTA) protein (i.e.,
MTA1, MTA2, or MTA3); retinoblastoma-binding protein (RBBP; also known as
RBAP48) 4 or RBBP7 (RBAP46). The MBD protein targets the complex to DNA while
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HDAC1 or HDAC2 enzymatically removes acetyl groups from histone tails. The Mi-2
subunit carries out chromatin remodeling in part by repositioning nucleosomes. The
p66α, p66β, RBBP4, and RBBP7 subunits are likely structural subunits of the complex
that interact with histone tails. The p66α/β proteins contain two highly conserved regions:
an N-terminal coiled-coil domain (CR1) and a C-terminal GATA-like zinc finger domain
(CR2) (12, 13). The MTA protein is thought to localize the complex to different cellspecific targets by associating with transcription factors (14).
The coiled-coil region of human MBD2 binds the p66α coiled-coil domain
(conserved region 1- CR1) forming a high affinity heterodimeric complex that recruits
Mi-2α/β and correlates with in vivo methylation dependent transcriptional repression
(15). This unique coiled-coil interaction results in a heterodimeric complex that forms
from anti-parallel association between two peptides that are largely monomeric in
isolation. Helical content and specific electrostatic interactions between charged residues
on the individual coiled coil domains drive the high affinity binding observed (16). This
suggests that isoforms of MBD2 and p66α exhibiting a reduction in helical content will
bind p66α with reduced affinity.
The MBD2 p55BR lies between the methyl-cytosine binding domain (MBD) and
the coiled-coil domains of MBD2. The first two-thirds of the region recruits the NuRD
core components RbAp46/48, HDAC1/2 and MTA1/2. Furthermore, two conserved
residues Arg286 and Leu287, establish critical contact points for complex formation
(Desai, MA, unpublished data). This region has been determined to display an
evolutionarily conserved, positive isoelectric point along with a largely unstructured
architecture in isolation. Despite its unstructured architecture, the p55BR enhances the
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affinity of MBD2 to methylated DNA by approximately 100-fold. (Desai, MA,
unpublished data).
NuRD complex components have previously been identified in organisms
throughout the metazoan line including plants and worms, and more recently, in the
sponges Amphimedon queenslandica (9) and Ephydatia muelleri (unpublished data,
Pohlman D.). Whether or not the gene products identified in these two sponge species
form an intact and/or functional NuRD complex remains unclear. Given the
characteristics of the human MBD2, and if methylation patterns are intrinsically different
between vertebrates and invertebrates, we initially asked the following questions: (1)
Does the MBD2 complex still target methylated DNA? (2) Does MBD2 recruit NuRD
components in the same manner? (3) What are the functional consequences of MBD2
knockdown?
To answer these questions, we cloned, expressed, purified, and determined the
methylation selectivity of Ephydatia MBD2 MBD by surface plasmon resonance (SPR).
We also cloned, expressed, and purified the coiled-coil domains from Ephydatia MBD2
and p66α and assessed complex formation using analytical ultracentrifugation (AUC) and
isothermal titration calorimetry (ITC). We assessed the temperature-dependent helical
properties of Ephydatia MBD2 and p66α in isolation and in complex using circular
dichroism (CD). We further cloned, expressed, and purified the full-length Ephydatia
p55BR along with a shorter version of the protein consisting of the first two-thirds of the
protein. RNAi-mediated knockdown of Ephydatia MBD2 and observation of subsequent
phenotypic effects was carried out by a collaborator.
Here, we show that Ephydatia MBD2 clearly prefers methylated DNA with a
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binding affinity close to that of human and chicken. However, the binding constant of the
sponge MBD2-p66α complex is approximately 1000-fold weaker than the human
complex. ITC of E.m.-H.s. complexes (either E.m. p66α:H.s. MBD2 or E.m. MBD2:H.s.
p66α) indicate higher affinity binding. We performed cross-species pull-down assays
involving the Ephydatia MBD2 p55BR and found that the protein recruits human MTA2
but not human HDAC1/2 or RbAp 46/48. RNAi-mediated knockdown of Ephydatia
MBD2 results in a low-growth phenotype marked by failure to form structures associated
with early development in sponges. These data suggest that sponges likely have the
capacity to carry out sophisticated epigenetic processes, including targeted chromatin
remodeling, that likely predate sponge emergence.

3.3 EXPERIMENTAL PROCEDURES

3.3.1 Purification of proteins and DNA:
The

coiled-coil

regions

of

human

MBD2b

(amino

acids

211-244),

p66α (amino acids 137-178) and Ephydatia muelleri MBD2 (amino acids 182-212) and
p66α (amino acids 58-101) were cloned and expressed with a hexahistidine tag and as
thioredoxin fusion proteins in a modified pET32a vector. The expression vectors were
transformed into the Rosetta BL21 (DE3- Invitrogen) E. coli strain, grown in Luria
Bertani medium at 37°C and induced with 1 mM isopropyl-β-d-thiogalactopyranoside at
an A600 ~ 0.8. The bacteria were harvested after 2 hours of induction and lysed
ultrasonically in the presence of B-PER reagent (Thermo Scientific). The soluble fraction
was passed over a nickel-sepharose column with the tagged protein eluted by a step

	
  

75	
  

gradient of imidazole and further purified by gel filtration over a Superdex-75 column
(GE Healthcare). The thioredoxin fusion proteins were used directly for analytical
ultracentrifugation (AUC) and isothermal titration calorimetry (ITC) studies. For circular
dichroism (CD) studies, clones were modified to incorporate a tyrosine residue just after
the thrombin cleavage site (for quantification of the isolated peptide by UV
measurement) and were expressed in a similar manner. After purification over a nickelsepharose column, the thioredoxin tag was separated from the rest of the peptide by
thrombin digest and isolated by gel filtration chromatography over a Superdex-75 column
(GE Healthcare). Specific mutations were introduced using the QuikChange Lightning®
site-directed mutagenesis kit (Stratagene) following the manufacturers protocol. The final
concentrations of all protein samples were determined by UV absorbance at 280 nm. The
17-bp complementary oligonucleotides (Table 2 of the previous chapter) were purchased
(Integrated DNA Technologies), annealed and purified as previously described. The
sequences were derived from the p16INK4a promoter known to be a native target sequence
for MBD2, as mentioned in the previous chapter.
Two E.m. MBD2 p55BR constructs were cloned into the pCMVTag2B (Stratagene)
vector in frame with an N-terminal Flag-tag sequence: full-length p55BR (amino acids
90-181) and short (amino acids 90-181). These constructs were used in the coimmunoprecipitation procedure discussed below.
3.3.2 Binding affinity:
Binding affinities were determined by surface plasmon resonance analysis on a
Biacore T100 system (GE Healthcare) as described previously. The binding affinity was
determined from steady state analysis of the SPR relative response at varying
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Binding affinity: Binding affinities were
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analytical ultracentrifuge (Beckman Coulter Inc.)3!
equipped with a four and eight-position
AN-60Ti rotor. Sedimentation was performed at 40,000 rpm, 20°C, under physiological
buffer conditions (20 mM Tris pH 8.0, 150 mM NaCl). Sedimentation profiles were
recorded using UV absorption (280 nm) and interference scanning optics. The partial
specific

volume

(V)

of

the

density (ρ) and viscosity (η) of the buffer were calculated using

sample,
the SED

NTERP program (25). Data was fit using a continuous size distribution (c(s)) and the
effective molecular weight determined from the resulting sedimentation coefficients with
the SEDFIT software (26).
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3.3.4 Isothermal titration calorimetry:
Protein samples were buffer exchanged into (50 mM Hepes pH 7.4, 150 mM NaCl)
and binding analyzed with an iTC200 Microcalorimeter (GE Healthcare). A total of 24
injections (1.5 µL each) of the p66α coiled-coil (100 µM) were injected into MBD2
and homologues (10 µM, 298 K, stir speed of 400 rpm, 120 seconds time delay between
injections). The resulting isotherms were auto adjusted for baseline and fit to a one-site
binding

model

using

Origin

7.0

software

to

determine

binding

constant

(KD) and enthalpy (ΔH) while the Gibbs free energy (ΔG) and entropy (ΔS)
of binding were calculated according to Equation 1.1,
−RTln(K) = ΔG = ΔH – TΔS (Equation 1.1),
where T is the temperature in Kelvin and R is the gas constant.

3.3.5 Circular dichroism:
CD spectra were collected on purified peptide samples (~33 mg/mL total protein in
10mM sodium phosphate, pH 6.5) with a JASCO J-715 CD spectrometer (JASCO Corp)
at 293 K, with a 1-cm path length, scanning from 190-260 nm with 0.5 nm interval at a
scanning speed of 50 nm/min. CD spectra were normalized to give molar ellipticity
values(θ) in degrees·cm2·dmol-1residue.
Helical content for each peptide was calculated from the ratio of the observed
θ222nm to the expected θ222nm for 100% helix as given by 40,000 × [(n − 4)/n], where
n is the number of residues. Thermal denaturation was followed at θ222nm from 277368K at 1 K intervals with a heating rate of 1 K/min. The data were fit to a simple two
state thermodynamic model of unfolding.

	
  

78	
  

Helical content prediction
The expected helical content for each peptide was calculated using the AGADIR
(27) algorithm with the N- and C-termini ‘free’, at 293 K, ionic strength of 0.02, and pH
6.5 to closely match the experimental conditions for CD. The predicted helical content
was used to help design amino acid changes that stabilize helix formation.

3.3.6 Co-immunoprecipitation studies:
Various MBD2 constructs were cloned into the pCMVTag2B (Stratagene) vector
in frame with an N-terminal Flag-tag sequence. HEK 293T cells were transfected with
the constructs (18 ug plasmid DNA) by calcium phosphate precipitation method

17

and

harvested after 48 hours. Cells were lysed and immunoprecipitated with anti-Flag M2
antibody (Sigma) and mouse IgG (Santa Cruz) controls according to the Sigma Flag-IPT
kit protocol (Sigma-Aldrich, Inc., St. Louis, MO). The precipitated proteins were then
analyzed for different components of the MBD2/ NuRD complex by western blot using
antibodies against RbAp48 (Abcam), HDAC2 (Millipore) and MTA2 (Santa Cruz).

3.3.7 RNAi studies:
The following MBD2 RNAi procedure carried out in Ephydatia muelleri was
provided by April Hill, Ph.D., Department of Biology, University of Richmond,
Richmond, Virginia.
Ephydatia muelleri gemmules were grown following the protocol in Rivera et al.
2011, with 2-3 gemmules sharing a single well. After the gemmules attached, 10,000 ng
of dsRNA was mixed with 1 mL of Strekal’s media in 3 of the six wells in which the
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sponges grew (Strekal and McDiffett 1974). After 24h, media was changed, and the same
3 wells received another 10,000ng of dsRNA. 48h after the original treatment, gemmules
were scored for growth, size, number of oscula, and canal structure. They were
photographed on a stereomicroscope.
dsRNA Synthesis:
The methyl binding domain of MBD2/3 was amplified from Ephydatia cDNA using
these primers: F: 5’ – CGACTCACTATAGGGTTGCGGGTGAAGGGCTTG – 3’, R: 5’
– CGACTCACTATAGGGGCCATCGCCAGGGGAAC – 3’. The primers contain
partial T7 sites that flank the ~204bp amplicon. The full T7 site was added in a
subsequent PCR, using a complementary primer that matched the partial T7 site. Both
reactions were run in the thermocycler at: 94°C for 3 min, 30 cycles of 94°C for 30s,
57°C for 30s, 72°C for 1 min, followed by a 5 minute final extension at 72°C. PCR
products were again run on a gel and the correct bands excised and purified. This product
was used to make double-stranded RNA (dsRNA) using the T7 RiboMAXTM Express
RNAi System (Promega). dsRNA was quantified using a NanoDrop.

3.4 RESULTS

3.4.1 Ephydatia muelleri MBD2 targets methylated DNA.
Alignment analysis indicates the Ephydatia and human MBD2 methyl-cytosine
binding domains share high identity (73%) as seen in figure 3.2, but less similarity
throughout the remainder of MBD2 (see the clustal analysis- figure 3.3). As can be
observed in figures 3.2 and 3.3, the sponge sequence contains all amino acids known to
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contact DNA and found in the loop connecting the central two beta strands of the beta
sheet: R24, G27, A30, H32, D34, F36, R46. This, along with the overall high identity
between Ephydatia and human MBD2 MBD, prompted us to surmise that the sponge
MBD would target methylated-CpG sites with similarly high affinity. To assess the
binding affinity of the Ephydatia MBD2 MBD for methylated and unmethylated
sequences DNA steady-state analysis of surface! plasmon resonance data was conducted,
as described in the previous chapter. To

!
!
!
!
!
!

allow for direct comparison of binding
stoichiometry, we normalized the relative
steady-state response to the amount of DNA
coupled to the sensor chip such that the
maximum steady-state response reflects the
number of binding sites on the DNA. As can

!
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!
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be seen in Fig. 3.4 and Table 3.1, both the
human and Ephydatia MBD2 MBD bind
mCpG

DNA

with

high

affinity

and

Figure 3.1: Domain organization of the
Homo sapiens MBD2 and p66α. GR, glycinearginine repeat region; MBD, methyl-binding
domain; CR1 is a coiled-coil domain; CR2
includes a GATA zinc finger domain.

stoichiometry of approximately one (KD = 0.19 ± 0.03 µM and 0.43 ± 0.09 µM,
respectively and Rmax = 1.2, for both human and Ephydatia). Both bind unmethylated
DNA with much lower affinity and high stoichiometry (KD = 82 ± 5 µM and 65 ± 2 µM
and Rmax = 7.3 and 7.9, respectively) indicative of a high degree of methylation
selectivity. However, human MBD2 selects methylated DNA with a 430-fold higher
affinity over unmethylated, whereas, Ephydatia MBD2 binds with a 150-fold higher
affinity than unmethylated DNA.
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ALPPGWKKEEVIRKSGLSAGKSDVYYFSPSGKKFRSKPQLARYLGNTVDLSSFDF

58

Human MBD2 MBD

59

Ephydatia MBD2 MBD

LP GWK+E V+RK+G SAGK+DVYYFSP GKKFRSKPQ+AR+LG+ VDL+ FDF
GLPSGWKREVVVRKNGQSAGKTDVYYFSPCGKKFRSKPQIARFLGDAVDLTCFDF

Figure 3.2: Alignment of the Homo sapiens and Ephydatia muelleri MBD2 methyl-cytosine
!
binding
domains.
CLUSTAL 2.1 multiple sequence alignment

EmMBD2a
EmMBD2b
HsMBD2b

MSSSSPPEYETVRTELRVKGLPSGWKREVVVRKNGQSAGKTDVYYFSPCGKKFRSKPQIA 60
MSSSSPPEYETVRTELRVKGLPSGWKREVVVRKNGQSAGKTDVYYFSPCGKKFRSKPQIA 60
---------------MDCPALPPGWKKEEVIRKSGLSAGKSDVYYFSPSGKKFRSKPQLA 45
:
.**.***:* *:**.* ****:*******.*********:*

EmMBD2a
EmMBD2b
HsMBD2b

RFLGDAVDLTCFDFSRAGSPGDGTQRRRARDRNLGSPGGGGGGGGGAGGHHSHSNGGTSS 120
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RYLGNTVDLSSFDFRTGKMMPSKLQKNKQRLRN--------------------------- 78
*:**::***:.*** .
. *:.: * **

EmMBD2a
EmMBD2b
HsMBD2b

AGNIVTRRSDHKPSSGSKPLSTNPLRP----SGPVRRTCGVIKLPVIWVAPPNNEQVRDE 176
-----------------KPLSTNPLRP----SGPVRRTCGVIKLPVIWVAPPNNEQVRDE 132
-----------------DPLNQNKGKPDLNTTLPIRQTASIFKQPVTKVTNHPSNKVKSD 121
.**. * :*
: *:*:*..::* ** *:
.::*:.:

EmMBD2a
EmMBD2b
HsMBD2b

CVILDQKRDVAVHVVVQTHWERRLGGFKPCDHATGSDIAFHRVPNGTVDGSATKKPAASQ 236
CVILDQKRDVAVHVVVQTHWERRLGGFKPCDHATGSDIAFHRVPNGT------------- 179
PQRMNEQP-------RQLFWEKRLQGLS-ASDVTEQIIKTMELPKGLQG----------- 162
::::
* .**:** *:. ....* . *
.:*:*

EmMBD2a
EmMBD2b
HsMBD2b

QTPAASASSKTQSSVLSHLPTPFLTSASPVSSLASQSPRSTNAPAGPPVHSGTDTLSANG 296
----------------------------------------------------------------VGPGSNDETLLSAVASALHTSSAPITG---------------------------- 189

EmMBD2a
EmMBD2b
HsMBD2b

PSASQQQTHSSTHSLVSNGSSAQTVELSLPLVTESVVRAQEERVRLIRQQLLAAQSISS- 355
--------------------------LSLPLVTESVVRAQEERVRLIRQQLLAAQSISS- 212
------QVSAAVEKNPAVWLNTSQPLCKAFIVTDEDIRKQEERVQQVRKKLEEALMADIL 243
. :**:. :* *****: :*::* *
.

EmMBD2a
EmMBD2b
HsMBD2b

------------------------------------SRAADTEEMDIEMDSGDEA 262

Figure 3.3: Clustal alignment of the Homo sapiens MBD2 versus Ephydatia muelleri MBD2a
and MBD2b.
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Normalized Relative Response (RU)
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Figure 3.4: Ephydatia MBD2 selectively targets methylated DNA. Steady state surface plasmon
resonance measurements are shown for MBD2 binding to immobilized double stranded methylated or
unmethylated oligonucleotides. The steady-state response was normalized to the amount of DNA
immobilized such that the maximum response reflects the stoichiometry of binding (n), as described
in the previous chapter.

Protein

DNA

Kd (µM) ± SE

Rmax *

Chi2 (x10-3)

HsMBD2
HsMBD2
cMBD2
cMBD2
EmMBD2
EmMBD2

mCpG
CpG(x3)
mCpG
CpG(x3)
mCpG
CpG (x3)

0.19 ± 0.03
82 ± 5
0.20 ± 0.01
74 ± 4
0.43 ± 0.09
65 ± 2

1.2
7.3
1.0
4.8
1.2
7.9

87
17
0.90
3.8
0.10
8.1

*Normalized such that Rmax reflects stoichiometry (n)
!
Table 3.1: Binding affinity. The dissociation constant (KD), Rmax, and Chi2 are given for
different protein and DNA complexes as determined by steady state analysis of surface plasmon
resonance studies.
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3.4.2 Key amino acid contact residues involved in high-affinity binding between the
human MBD2 and p66α coiled-coil regions are found in Ephydatia muelleri.
The human and Ephydatia MBD2 CC regions share 46% identity, whereas the p66α
peptides share only 37% identity. Yet, the key amino acid residues involved in the human
MBD2 and p66α coiled-coil complex are largely conserved in Ephydatia (Figures 3.1 and
3.5), suggesting that, like the human CC regions, binding is largely driven by key
hydrophobic and electrostatic contacts, and the helical properties of the peptides.
The coiled-coil typically consists of two or more α-helices wrapped around one
another. Coiled-coils are characterized by amino acid sequences forming a heptad repeat
pattern, with positions designated abcdefg; dimerization interfaces form from
hydrophobic side chains at the a and d positions. In this sequence, the first and fourth
residues are hydrophobic, and residues in the fifth and seventh position are primarily
charged or polar (18). Coiled-coil segments may be unfolded in monomeric form and
then fold during interaction with a binding partner (19). A two-state transition often
describes the folding and unfolding of coiled coils, i.e., unfolded peptide monomers
cooperatively fold to form coiled-coil dimers or oligomers (18).
Parallel and antiparallel coiled-coil dimerization results largely from the
interdigitation and burial of hydrophobic side chains of one helix into its partner. The
human MBD2/p66α CC interaction represents an anti-parallel orientation with
intermolecular, vertical contacts between branched hydrophobic residues. The vertical
interactions form between residues in the a position of the heptad repeat of one helix and
the d’ of the other, and the a’ and d positions. Triplet repeats of branched hydrophobic
residues placed in the a’-a-a’ positions further promote heterodimerization (16). The
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position of hydrophobic residues in human MBD2 and p66α represents an arrangement
found to strongly favor heterodimeric, antiparallel coiled-coil formation (16, 20). More
specifically, hydrophobic interdigitation between the two coiled-coils presents as
RILVLLI (p66α residues are in italics) (16).
As mentioned previously, Ephydatia MBD2 p66α CC regions share high identity
with their human counterparts, regarding the amino acid residues involved in the coiledcoil binding interface. E.m. MBD2 presents a VVL sequence rather than IVL, while
Ephydatia p66α offers an RLLV the a-a’ interdigitated sequence between the Ephydatia
peptides is likely represented by RVLVLLV. Since the side chain of valine is shorter than
leucine or isoleucine, the presence of valine-227 in human MBD2 may allow closer
proximity, and therefore tighter packing, of the surrounding side chains at the interface.
Conversely, the additional valines present at the E.m. interface may prevent tighter
packing, as the valine side chain may be unable to reach into the binding pockets as well
as the isoleucine or leucine residues present in the human peptides.
When the glutamate at position 224 of human MBD2 was mutated to a glycine,
decreases were observed in both helicity and binding to p66α, showing that pre-formed
helical content is necessary for binding; this residue is not found on the binding surface
between the two CCs (16). The coiled-coil regions of Ephydatia MBD2 and p66α both
have several amino acids that disrupt alpha-helicity (Figure 3.2). Since the high affinity
interaction between human MBD2 and p66α was shown to be strongly influenced by the
helical propensity of both prior to binding, the Ephydatia orthologs are unlikely to
display the same high helical content and, therefore, the same degree of binding as the
human peptides.
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Figure 3.5: Human and Ephydatia MBD2 and p66α coiled-coil sequence alignments. Top, a sequence
alignment of the coiled-coil (cc) domains from human and Ephydatia p66α and MBD2 is shown with key
hydrophobic (yellow) and ionic/polar (cyan) contact residues highlighted and the heptad repeat (a-g) indicated
above and below the amino acid sequences. Bottom, an anti-parallel sequence alignment showing the position
of contact residues between the human and sponge proteins, with amino acid residues known to disrupt alphahelicity highlighted (grey) for Ephydatia.
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3.4.3 Ephydatia MBD2 and p66α coiled-coil regions remain largely monomeric in
solution.
The human MBD2 coiled-coil region does not form homo-oligomers as often
observed with coiled-coils. Indeed, the protein remains monomeric in isolation up to a
concentration of 300 µM. The human p66α coiled-coil, however, forms homo-dimers in
concentrations above 50 µM, though the monomer remains the dominant form (15).
Preliminary size exclusion chromatography (SEC) experiments suggested weak binding
between the Ephydatia MBD2 MBD and p66α coiled-coil regions. We then performed
sedimentation velocity AUC studies so as to assess the homo-dimerization versus homooligomerization potential of each peptide in isolation and the hetero-dimerization
potential in complex. These results indicate that Ephydatia MBD2 coiled-coil also
remains monomeric in isolation up to a concentration of 100 µM (Figure 3.6). Though the
Ephydatia p66α coiled-coil region largely exists as a monomer at a 100 µM
concentration, it does exhibit a tendency to homo-dimerize. The sedimentation velocity
study also indicates that when the two proteins are combined at final concentrations of
100 µM, monomers, heterodimers, and hetero-oligomers exist in solution. Given that the
binding constant between the two sponge coiled-coils is 25 µM, a concentration at only
four times the KD (100 µM) of a weakly binding complex, is likely to show multiple
species.
The weak binding suggested by SEC and AUC, along with the low helical
propensity predicted by Agadir (see results below), prompted us to turn our attention to
CD and ITC analyses to further explore the helical and binding properties of the
Ephydatia coiled-coil proteins.

	
  

87	
  

EmMBD2CC
Complex
Emp66αCC

!
Figure 3.6: The Ephydatia coiled-coil domains remain largely monomeric in isolation.
Analytical ultracentrifugation analysis was performed on the individual coiled-coil domains and the
sedimentation velocity fit using a continuous size distribution (c(s)). The results are shown for 100
uM concentrations of MBD2 and p66α coiled-coil domains.

3.4.4 Ephydatia MBD2 and p66α display lower helical propensity than their human
counterparts.
Agadir is a prediction algorithm that predicts helical propensity of monomeric
peptides in solution, and is based on the helix/coil transition theory (21). The algorithm
predicts that the Ephydatia MBD2 and p66α coiled-coil domains do not have the same
tendency to form α-helices in isolation as with the human orthologs (Table 3.2). CD
analyses were performed on the isolated domains, so as to determine the relative helical
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content of the coiled-coil regions in isolation in comparison to that predicted by Agadir.
Human MBD2 (25%) and p66α (66%) are more helical than Ephydatia MBD2 (5%)
and p66α (20%). The thermal stability of the different coiled-coil complexes was
determined by following molar ellipticity at 222 nm (θ222 nm) as a function of
temperature. No cooperative transition was observed during the melt of the Ephydatia
coiled-coils while the human variants do experience this phenomenon. High affinity
binding between human MBD2 and p66α depends on the helical propensity of their
coiled-coils (16). Since numerous amino acids known to disrupt alpha-helical structure
are present in both Ephydatia CC regions, we therefore predicted a lower binding
constant for the Ephydatia coiled-coil interaction.
The human complex melts at 338K while the sponge complex does not exhibit a
cooperative phase transition associated with melting (figure 3.7, bottom). However, the
complex could only be accurately measured at 13uM, which is below the 25 uM binding
constant; only a small fraction would be bound at this concentration. The predicted versus
calculated helicities differed significantly for the Ephydatia coiled-coils. Limitations for
the Agadir algorithm exist that cause the program to over or underestimate the helical
content of peptides; these factors may apply in this scenario. For example, the algorithm
contains no mode for assessing side-chain interactions. The algorithm also assumes that
there is no energy coupling, other than electrostatic, between residues in the random-coil
state, although interactions may also result in the formation of beta-turns in solution; the
algorithm may predict a random-coil. Further, peptides may aggregate in solution thereby
altering helical propensity. This is another case that Agadir is unlikely to incorporate into
the prediction. Also, the presence of the tyrosine residue at the beginning of the amino
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acid sequence likely disrupts the helicity of the peptide; side-chain interactions with the
peptide helix may alter both the geometry and CD signal. CD analysis of polyalaninebased peptides with an N-terminal tyrosine residue located at either end of the chain
sometimes associates with a positive band at 222 nm (22). Thus, a discrepancy emerges
between the predicted and calculated (i.e., an over-estimation of helicity by Agadir).
!
!
!
!
Coiled1coil!domain!
HsMBD2!
Hsp66α!
EmMBD2!
Emp66α!
a!!Based!on!the!AGADIR!algorithm!
b!!Based!on!CD!measurements!

Helical!propensity!
in!isolation!
Predicteda!
Calculatedb!
40!
25!
55!
66!
26!
5!
8!
20!

Table 3.2: Helical content of the Ephydatia MBD2 and p66α coiled-coils. Percent helicity as
predicted by AGADIR and calculated from the circular dichroism molar ellipticity at 222 nm (θ222
nm) is given for the Ephydatia muelleri and Homo sapiens coiled-coil domains.
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Figure 3.7: Circular dichroism spectra of Ephydatia coiled-coils in isolation and in complex. Top: circular
dichroism spectra. Bottom: a thermal melt indicating the temperature dependence of the molar ellipticity at 222
nm from 293 to 358K.
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3.4.5 Ephydatia MBD2 and p66α coiled-coil regions bind weakly, but bind to human
p66α and MBD2 coiled-coils, respectively, with higher affinity.
Preliminary SEC evidence suggested that an Ephydatia muelleri (E.m.) MBD2p66α complex binds very weakly

(data not shown), converse to the tight binding

experience by the coiled-coils in the human (H.s.) complex. We set out to more
accurately determine the binding constant for the E.m.-E.m. complex. Our lab previously
determined that the high affinity of the human coiled-coils results from conserved
hydrophobic and electrostatic interactions between the coiled-coils (CC) and their helical
content. Since the Ephydatia coiled-coil peptides largely contain the same interacting
residues, and yet likely experience weak binding as a result of predicted reduced helicity,
we were curious if the respective Ephydatia coiled-coil peptides would form higher
affinity complexes when combined with the human coiled-coil regions (i.e., E.m.
MBD2/H.s. p66α, E.m. p66α/H.s. MBD2).
Preliminary SEC data suggested that the E.m.-H.s. complexes bind with higher
affinity (data not shown). ITC was then performed using thioredoxin fusion constructs of
the coiled-coil domains. Exothermic heat was generated with each injection in all
experiments. The binding isotherms (Figures 3.8 and 3.9), and the measured binding
affinity (KD), free energy (ΔG), enthalpy (ΔH), and entropy (-ΔTΔS) for each complex
(Table 3.3) show that indeed the Ephydatia peptides bind with higher affinity when in
complex with the human (H.s. p66αCR1/E.m. MBD2CC: KD- 390 ± 30 nM; E.m.
p66αCR1/H.s. MBD2CC: KD- 1.3 ± 0.11 µM) as compared with the Ephydatia only
complex (24 ± 0.12 µM). Each complex binds with a stoichiometry of approximately 1:1
(n ranges from 0.99 to 1.4, Table 1) consistent with heterodimer formation.
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Of the binding interactions tested, E.m. p66α for E.m. MBD2 complex formation
reflects the most unfavorable change in entropy upon binding (TΔS: -1.097 kcal/mol)
despite a favorable change in enthalpy (ΔH -7.405 ± 0.1001 kcal/mol) supporting the
notion that pre-formed helicity is an important determinant of binding affinity. The ITC
results further establish a hierarchy regarding favorability of complex formation: H.s.H.s.>E.m. MBD2-H.s. p66α >H.s. MBD2-E.m. p66α >E.m.-E.m. (highest to lowest
favorability).
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Figure 3.8: Binding analysis of Ephydatia and human MBD2 and p66α coiled-coil interactions. Isothermal
titration calorimetry studies indicating the resulting fit and associated data are shown for human and Ephydatia
MBD2 and p66α coiled-coil domains binding interactions. Top left: human MBD2 and p66α. Top right:
Ephydatia MBD2 and p66α. Bottom left: Human MBD2 and Ephydatia p66α. Bottom right: Human p66α and
Ephydatia MBD2.
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Figure 3.9: Binding analysis of Ephydatia and human MBD2 and p66α coiled-coil interactions. Isothermal
titration calorimetry studies indicating the experimental data (top panel) and resulting fit (bottom panel) are
shown for human and Ephydatia MBD2 and p66α coiled-coil domains binding interactions. Top left: human
MBD2 and p66α. Top right: Ephydatia MBD2 and p66α. Bottom left: Human MBD2 and Ephydatia p66α.
Bottom right: Human p66α and Ephydatia MBD2.
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!
!
!
!
Hsp66αCR1/HsMBD2CC
!
Hsp66αCR1/EmMBD2CC
!
Emp66αCR1/HsMBD2CC
!
Emp66αCR1/EmMBD2CC
!
!

KD (nM)!

n!

∆H (cal/mol)!

T∆S (cal/mol)!

∆G (cal/mol)

48 ± 7!

1.3!

-9,934 ±127.6!

-55.7!

-9,878!

390 ± 30!

1.4!

-8,989 ±103.6!

-238!

-8,751!

1,300 ± 110!

1.3!

-8,922 ±63.14!

-903!

-8,019!

24,000 ± 1,200!

0.99!

-7,405 ±100.1!

-1,100!

-6315!

Table 3.3: Binding affinity analyses of Ephydatia and human MBD2 and p66α coiled-coil
interactions. The dissociation constant (KD), change in enthalpy (ΔH), entropy (-TΔS), Gibbs free
energy (ΔG), and apparent stoichiometry (n) derived from isothermal titration calorimetry studies are
given for the coiled-coil complexes between human and Ephydatia p66α and MBD2.

3.4.6 The Ephydatia p55 binding region does not recruit human NuRD core
components.
The region between the MBD2 MBD and coiled-coil domain enhances the affinity
of MBD2 for DNA and behaves as an intrinsically disordered region in isolation, in the
context of the full-length protein, and when bound to DNA (Desai, M., et al., unpublished
data). The first and second regions of the human MBD2 p55BR (amino acids 240-316)
are sufficient to recruit RbAp48, HDAC2, and MTA2, although showing a somewhat
weaker interaction with MTA2 as compared to the full-length p55BR (Desai, M., et al.,
unpublished data). The human and sponge MBD2 p55BR share 30% identity and nearly
identical isoelectric points (pI approximately 10). Without a reliable means of assessing
the capacity of E. muelleri MBD2 p55BR to recruit NuRD components in sponge cells,
we investigated whether or not the E. muelleri p55BR interacts with the core components
of human NuRD (MTA1/2/3, HDAC1/2, and RbAp46/48). Full-length, flag-tagged
sponge p55BR was expressed in human epithelial kidney cells (HEK 293T) and
immunoprecipitations of cell lysates with an anti-flag antibody were followed by western
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blot analysis to identify the human NuRD components interacting with the flag-tagged
p55BR. Figure 3.10 suggests that despite a weak band for human MTA2, full-length

Emp55BREphydatia
FL interaction
RbAp/HDAC/MTA
p55BR of MBD2 does notwith
significantly
recruit human MTA2, RbAp48, and
HDAC2.

p55BR Emp55BRFL

Inputs

Fla
g
IgG IP
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gI
IgG P
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gI
IgG P
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RbAp48
HDAC2
MTA1
MTA2
Non-specific band

MTA2

Figure 3.10: Ephydatia MBD2 p55BR does not recruit human NuRD components. The
Ephydatia MBD2 p55BR-pCMVTag2B plasmid and an empty vector control were transiently
transfected into high-transfection-efficiency HEK 293T cells.

3.4.7 RNAi knockdown of EmMBD2 causes atypical growth patterns in Ephydatia
muelleri.
Preliminary data from the RNAi-induced knockdown of the Ephydatia MBD2/3 in
developing sponges carried by out a collaborator resulted in an atypical growth
phenotype early in development. This phenotype was characterized by abnormal growth
patterns at the leading edge of tissue formation and failure to form complete structures
associated with early developmental steps (i.e., canal structures and osculum).

3.5 DISCUSSION
The leap from unicellularity to multicellularity represents a major evolutionary step,
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and sponges exemplify an early and successful evolutionary attempt at a collective
existence. But, it is currently unknown to what extent the evolution of morphological
complexity was driven by changes in gene content or regulation. Therefore, as the most
basally extant organism in the animal lineage, Poriferans represent a ripe target of
epigenetic investigation. The epigenetic capabilities of this most primitive and ancient
multicellular organism not only represent a base set for all animals, but also provides
insight into the epigenetic machinery present in the last common ancestor to all
metazoans.
Here, we have presented biophysical analyses pertaining to the ability of MBD2 in
the freshwater desmosponge, Ephydatia muelleri, to bind methylated DNA and recruit
NuRD components. These studies underscore how changes in MBD2 amino acid content
over time may have influenced the emergence of the NuRD complex in response to a
changing DNA landscape. We specifically find that: (1) the capacity to carry out
methylation-specific epigenetic mechanisms is present in sponges; (2) E. muelleri MBD2
and p66a can bind, albeit weakly, through their respective coiled-coil domains, despite
minimal pre-formed helical content; (3) cross-species pull-downs show the E. muelleri
MBD2 p55BR does not recruit human NuRD core components MTA2, Rbap46/48 or
human HDAC1/2; (4) RNAi knockdown of MBD2 in E. muelleri results in abnormalities
to growth and development.
Previous work has established that helical content can modulate binding affinity of
the MBD2 and p66α coiled-coil domains (16). The CD and ITC data suggest the
importance of pre-formed helical content regarding binding affinity and specificity. The
Ephydatia MBD2-p66α coiled-coil interaction further supports the notion that differences
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in helical content dictate high affinity coiled-coil binding for the human orthologs, and
thus, overall NuRD complex formation. As we have observed, though, sponge MBD2
and p66α need not display high helical content in order to interact. Since MBD2
homologs (e.g., MBD3, MBD3L1, MBD3L2) are not found in the genomes of
Amphimedon or Ephydatia, competition for p66α binding is likely reduced in the context
of forming different NuRD complexes. Thus, high affinity binding may have become
necessary only when other isoforms emerged.
MBD2 homologs emerge at the same time as the vertebrate methylation pattern (4),
which includes largely unmethylated CGIs, suggesting a role for these proteins in
regulating genes with unmethylated CGIs. Data collected from the RNAi-mediated
knockdown of MBD2 supports the notion that sponges have a capacity for interpreting
methyl-cytosines as an epigenetic mark. Ephydatia MBD2 targets methylated sites with
similar high-affinity binding observed in human and chicken MBD2 isoforms. Sponges
also lack homologs of MBD2 that may alter the distribution, and thus the functional
consequence, of MBD2 on DNA. Therefore, sponge MBD2 may not need to bind DNA
as tightly in order to bring about a physiologic response.
The role of DNA methylation and methyl-cytosine binding domains has clearly
changed during the course of metazoan evolution. Expansion of the methylation
landscape in vertebrate genomes created an environment in which new dynamic
properties of regulatory proteins were required; expansion of the first MBD’s functional
role may have occurred concomitant to changes in the DNA methylome. At the dawn of
animals, however, the methylation landscape may have initially dictated little need for
variations of methyl-cytosine binding domain proteins. There may have been little
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evolutionary pressure for the presence of different NuRD complexes that show varying
degrees of DNA methylation selectivity and provide distinct functional roles.
MBD2-directed targeting to mCpGs clearly serves an important developmental role
for Ephydatia. It is however unclear if the developmental abnormalities observed in
Ephydatia result from actions directly mediated by an intact NuRD complex. Despite the
observations collected from our cross-species experiments, it remains reasonable to
expect the Ephydatia p55BR to recruit Ephydatia NuRD components in sponge cells.
Differences in amino acid composition between the human and sponge proteins in
question may prevent E.m-H.s. binding, but not necessarily between the sponge proteins.
Human and Ephydatia RbAp share 82% amino acid identity and 80% identity is shared
between the human and sponge HDAC whereas only 42% identity exists between those
of MTA2. Only 30% identity is shared between the MBD2 p55BR of both species.
Though sequence differences likely dictate the results observed in these studies, pulldown analysis in sponge cells is a necessary next step to determine if NuRD formation
occurs in Ephydatia muelleri.
It is also possible that a NuRD complex may not form in its entirety in E. muelleri.
That supposition, however, does not preclude the formation of a functional complex that
targets methylated DNA and carries out chromatin remodeling. Our observations support
the possibility of such a complex. Furthermore, the NuRD complex is unique in that it
couples two separate DNA-related functions, whereas most co-repressor complexes
perform only one action on DNA (23). It is reasonable that a sponge precursor to the
NuRD complex may involve only a single regulatory mechanism. However, we cannot
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conclude that MBD2 does not direct NuRD complex assembly in E. muelleri without an
ability to perform pull-down assays in sponge cells.
The paths leading to novel protein functions likely proceed through states in which
isoforms and relatively unstable structures emerge and coexist (24); one or more of these
forms may perform new tasks beneficial for the organism resulting in the evolution of a
new biological function. This scenario might very well be represented by the subtle
changes over time in the MBD2 p55BR and the coiled-coil regions of p66α, MBD2, and
the remainder of the MBD family as well. Indeed, the expansion of the MBD family
appears to correlates with the evolution of their C-terminal coiled-coil regions.
Research continues to show that NuRD activity largely depends on its specific
subunits and their interactions. Despite that which is known about the NuRD complex,
much about the mechanisms of component recruitment, assembly, and localization to
specific genomic targets remain unclear. These mechanisms undoubtedly influence
subunit binding affinity and genomic selectivity by the complex, and therefore constitute
an essential area of study regarding this important genetic regulator. Continued study of
the evolution of NuRD subunits over time may elucidate these mechanisms. Future
studies may also uncover how the changing epigenetic landscape, associated with both
the metazoan-eumetazoan and the invertebrate-vertebrate transition allowed for, or was
mediated by, the evolution of the NuRD complex.
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Chapter 4- Summary

Changes to the DNA methylation landscape during the invertebrate to vertebrate
transition may have accompanied evolutionary pressure for expansion of the MBD
family. Global methylation patterning likely necessitates a larger ensemble of
functionally diverse MBD proteins so as to expand regulatory capacity. Much like an
increase in the quantity and complexity of data contained within a database requires an
expansion of the database management systems that organize and analyze the data within
that collection of information. Or, if one views DNA as a manuscript, alterations to the
story may increase both the cast of characters and the story’s complexity; more people
may become involved in interpretation of the story’s account of events.
As with the works of Shakespeare, we are still developing our understanding of the
meaning of the stories provided to us by nature, and interpreting the menagerie of
characters encoded within the script. Also like Shakespeare, nature has left us several
enigmatic characters and plots we have yet to fully comprehend. The studies presented in
this thesis, Evolution And Divergence Of The Structural And Physical Properties Of DNA
Binding By Methyl-Cytosine Binding Domain Family Members 2 And 3, pertain primarily
to two characters in the DNA methylation story. We more specifically provide details
regarding the mystery surrounding MBD3 function and the MBD2-mediated capacity of
primitive animals to carry out methylation-specific epigenetic mechanisms.
In chapter two, ‘Probing the dynamic distribution of bound states for methylcytosine binding domains on DNA, we provide additional details regarding the DNA
binding properties of MBD2 and MBD3. More specifically, this study provides details
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regarding previously unidentified MBD3 binding properties and potential biological
function. Studies establish the two proteins as important epigenetic regulators, and both
have been analyzed extensively for possible functional differences and similarities. But
although MBD2 has been well characterized, MBD3 continues to be scrutinized
regarding its structure and biological function. We found that MBD3 does modify the
distribution of MBD2 on DNA such that MBD2 spends less time on CpG sites. Thus
MBD3 could help prevent gene silencing by MBD2 at unmethylated gene promoters and
enhancers depending on the relative concentration of the two proteins and cellular
context. These findings correlate with the observations that both MBD2 and MBD3 are
found at unmethylated CGIs, but MBD2 binds with much greater affinity and likely
excludes MBD3 from methylated CGIs. The data establishes a structural basis for the
relative distribution of MBD2 and MBD3 on genomic DNA and help explain their
observed occupancy at CpG-rich promoters. Further in vivo detail is necessary, though, to
better assess MBD3 capacity for modulating MBD2 distribution at these sites and the
functional consequence of such activity.
In chapter three, ‘Sponge MBD2 targets methylated DNA and recruits NuRD
components’, we demonstrate that sponges have an MBD2-mediated capacity for binding
methylated DNA sites and recruiting NuRD components in vitro. We further show that
knockdown of MBD2 in the freshwater desmosponge, Ephydatia muelleri, promotes an
abnormal growth phenotype, illustrating the importance of the protein for sponge
development. Thus, at the dawn of animals, molecular machinery was in place allowing
for methylation-specific epigenetic regulation that influences developmental processes.
Further assessment should involve the ability of E. muelleri MBD2 to recruit sponge
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NuRD components in vitro and in vivo along with analysis of NuRD complex
functionality in vivo.
One might associate protein specificity with a lack of structural and functional
versatility over evolutionary time. Indeed, proteins with absolute functional specificity
and structures are likely to respond less readily to selective pressures. Structural
variability consequent to mutation, gene duplication, or other processes, can lead to
structural flexibility that endows proteins with functional promiscuity and/or, over time,
allow structural ensembles to diverge into groups separated by distinct structures and
functions. This situation may have allowed for the divergence of the MBD family from
the ancestral MBD2/3. The observed flexibility in the finger-like projection connecting
the central two strands of the β-sheet of MBD2 and MBD3 may exemplify a relationship
between structural flexibility and evolvability or, at least, functional promiscuity.
Expansion of both the MBD family and the NuRD functional repertoire may also have
been promoted by subtle changes over time within the p55BR and coiled-coil regions of
MBD2 and MBD3.
Much remains to be learned regarding the evolutionary and biochemical
foundations of epigenetic processes. Hopefully, this dissertation provides some useful
insights into the emergence and evolution of the key epigenetic regulators presented and
how those molecular entities influence heritable changes in gene activity.
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